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Introduction: The neurobiological bases of pervasive developmental disorders (PDD) 
and schizotypy are not well established.  In addition there are clinical overlaps between 
the two which can make diagnostic determination difficult.  The primary aim of this 
thesis was to explore the relationship between PDD and schizotypy by examining their 
associated clinical and brain structural features in a group of cognitively impaired 
adolescents.  Methods: 138 adolescents receiving special educational assistance and 62 
typically developing controls were recruited.  Schizotypal features were measured using 
the Structured Interview for Schizotypy (SIS) and PDD features were measured using the 
Social Communication Questionnaire (SCQ).  Each participant also received a 
standardised clinical interview and a magnetic resonance imaging (MRI) scan.  Whole 
brain volume, midsagittal corpus callosum area and prefrontal lobe volume and 
gyrification index (GI) were measured using automated, semi-automated and manual 
region of interest techniques.  The subjects in special education were considered in 
different groupings in three main analyses.  In the first, the SIS was used to divide the 
subjects into those with and without schizotypal features.  In the second, the standard 
SCQ cut-offs were used to divide the subjects into those with autism, those with non-
specific pervasive developmental disorder (PDD-NOS) and those with neither.  Finally, 
both the SIS and the SCQ were used contemporaneously to divide the subjects into 6 
groups: schizotypal; autistic; PDD-NOS; comorbid schizotypy and autism; comorbid 
schizotypy and PDD-NOS; and neither schizotypal nor autistic.  In each analysis the 
groups were compared to each other and to the controls with respect to the clinical 
features and brain structural measures.  Results: The schizotypal subjects showed an 
increase in right prefrontal volume and changes in the anterior and posterior corpus 
callosum relative to those without schizotypy and the controls.  The autism group had 
reduced right prefrontal GI relative to the other groups as well as anterior callosal 
 
changes.  The PDD-NOS group had the highest level of psychiatric symptomatology on 
the CIS, in particular those who were comorbid for PDD-NOS and schizotypy.  This 
comorbid group, both clinically and structurally resembled the schizotypy group rather 
than the PDD-NOS group.  Conclusions: Distinct neuroanatomical differences can be 
seen in educationally impaired adolescents with schizotypal features and in those with 
autistic features.  These can be related to the observed clinical impairment and may help 
to distinguish these disorders in the future.  It is possible that adolescents with features of 
both schizotypy and PDD-NOS suffer from an underlying schizophrenia spectrum 
disorder rather than an autistic spectrum disorder.   
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Chapter 1 
Historical Perspectives, Modern Diagnostic Criteria and 




1.1 The History of Schizotypy 
 
Although there is no agreed definition of what the term schizotypy actually encompasses, 
it is used in modern day psychiatry to describe a combination of personality and 
behavioural features like those observable in the relatives of schizophrenic individuals 
(and possibly premorbidly in people with schizophrenia), and mild forms of the 
psychopathologies which are the key features of schizophrenia itself.   It is not surprising 
therefore that the evolution of the term has been influenced by descriptions of the 
aberrant but non-psychotic relatives of individuals with schizophrenia, and by clinical 
observations of mild schizophrenia-like syndromes which do not meet diagnostic criteria 
for the full disorder.1  The current usage of the term reflects a convergence of these 
family based and clinical approaches to describing the hinterlands of schizophrenia and 
has been strongly influenced by the Danish-American Adoption Study2 and the 
subsequent operationalisation of diagnostic criteria for schizotypal personality disorder.    
 
The conceptualisation of schizophrenia, not as a discrete entity, but rather as representing 
the severe end of a spectrum of disorder is not new and is in fact as old as the diagnosis 
of schizophrenia itself.  In 1908 Eugen Bleuler, writing about schizophrenia noted: 
 “If one observes the relatives of our patients…, one often finds in them 
peculiarities which are qualitatively identical with those of the patients 
themselves, so that the disease appears to be only a quantitative increase 
of the anomalies seen in the parents and siblings”3   
 
Similar ideas were also held by Emil Kraeplin,4 although it was Bleuler who proposed 
broadening Kraeplin’s dementia praecox to include what he termed latent schizophrenia.  
He proposed latent schizophrenia as essentially a forme fruste of schizophrenia with 
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 “all the symptoms and all the combinations of symptoms which are 
present in the manifest type of the disease….irritable, odd, moody, 
withdrawn or exaggeratedly punctual people…often one discovers a 
concealed catatonic or paranoid symptom”3   
 
He also suggested that it was the most common form of schizophrenia but that those 
affected rarely present for treatment.3   
 
Other early investigators also noted unusual patterns of personality and behaviour in the 
relatives of schizophrenic patients.  Kretschmer, who viewed the major psychoses as 
extreme ends of the continuum of normal, described schizoid personality not only in the 
relatives of schizophrenic patients but also as a premorbid personality trait in those who 
later went on to develop schizophrenia.  According to Kretschmer the central features of 
the schizoid personality were solitariness, humourlessness and eccentricity.5  He also 
described “autistic withdrawal” where the schizoid individual, being preoccupied with 
their own thoughts and interests, would shut themselves away from society.  Kallmann, in 
a study of the pedigrees of over 1000 individuals with schizophrenia, found that 
schizophrenia occurred in approximately 10% of relatives of probands but schizoidia 
appeared in another 25%.  He described two types of cases within schizoidia – borderline 
cases and schizoid psychopaths - both of which were characterised by deficits in social 
and emotional functioning with eccentricities and autistic preoccupations.6   
 
The term schizotypy itself was first introduced in the 1950s by Rado in the form 
schizotype,7 short for schizophrenic genotype.  Rado, a psychodynamic psychotherapist, 
believed that the essential components of the schizotype were “an integrative pleasure 
deficiency” and a distorted awareness of the physical self.  These core deficits led to 
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interpersonal dependency, oversensitivity to rejection, difficulty in forming relationships, 
fearfulness and cognitive disorganisation.  He asserted that when under severe stress the 
schizotype was at high risk of developing full-blown schizophrenia.  Meehl expanded on 
this idea further using the term schizotaxia to denote an inherited neurointegrative deficit 
which predisposed to schizophrenia, with schizotypy the behavioural phenotype of this 
deficit.  To Meehl, schizotypy was comprised of four components – anhedonia, cognitive 
slippage (mild thought disorder), interpersonal aversiveness, and ambivalence.  In a 
similar manner to Rado he posited that environmental influences acting on the schizotype 
determined whether or not they go on to develop schizophrenia.8   
 
Certain themes run through much of the work described above in particular eccentricity, 
social withdrawal or autism, and anhedonia.  Attenuated positive symptoms are included 
in Bleuler’s latent schizophrenia but do not occupy a central position, while Rado’s 
cognitive disorganisation (and hence Meehl’s cognitive slippage) were initially regarded 
as secondary features.  However, since its introduction by Rado the term schizotypy has 
been expanded to include mild positive symptoms which are not present in such a degree 
to permit the diagnosis of schizophrenia, including magical thinking and perceptual 
distortions.  This largely results from the influence of the work of Hoch and colleagues in 
the late 1940s and 1950s who identified “schizophrenic-like” symptomatology in 
individuals who were in psychoanalysis for the treatment of neurotic disorders.  
Classified as having “pseudoneurotic forms of schizophrenia” these individuals were 
described as suffering from attenuated forms of schizophrenia with abnormal thought 
processes, tangentiality, perceptual distortions and brief psychotic symptoms.9  Hoch’s 
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work influenced the DSM-II criteria for the diagnosis of latent or borderline 
schizophrenia and most crucially those used in the Danish-American Adoption Study.2   
 
Latent or borderline schizophrenia was included in DSM-II in 1968 as a diagnostic 
category to describe a disorder with many of the features of schizophrenia but without 
clear-cut psychotic symptoms.  The Danish-American Adoption Study, which examined 
the biological relatives of schizophrenic adoptees, found borderline schizophrenia to be 
present in around 15% of relatives of schizophrenic adoptees compared to 1% of relatives 
of control adoptees.2  The criteria used in this study to diagnose borderline schizophrenia 
were essentially the same as those proposed in DSM-II and comprised dysfunction in 5 
domains: thinking (atypical and vague, ignores reality), experience (brief cognitive 
distortions, depersonalisation, micropsychosis), affective (anhedonia), interpersonal 
behaviour (lacks depth, chaotic), and psychopathology (multiple inconsistent neurotic 
symptoms and severe generalised anxiety).2  This characterisation of borderline 
schizophrenia forms the basis of much of our current understanding of schizotypal 
personality disorder.   
 
At this time the term schizoid remained in common use although, due largely to 
psychodynamic influences, had come to encompass a wide range of difficulties with 
intimacy and affection well beyond its original meaning.  This was addressed with the 
advent of DSM-III, when the modern diagnostic categories relevant to schizophrenia 




1.2 Current Diagnostic Categories Related to Schizotypy 
 
Schizotypal Personality Disorder 
In preparation for the construction of DSM-III a re-examination of the Danish-American 
Adoption Study was carried out by Spitzer et al.10  They reviewed 86 out of the 321 cases 
from the Danish-American Adoption Study, approximately half of which were diagnosed 
in the original study with borderline or possibly borderline schizophrenia with the 
remainder having non-schizotypy diagnoses.  Based on these interviews Spitzer et al 
derived 8 criteria which they felt best discriminated these two groups and these were 
included in DSM-III under the label schizotypal personality disorder, which replaced 
borderline schizophrenia.10  Kendler notes that schizotypal personality disorder contains 
some criteria which bear more resemblance to Bleuler’s latent schizophrenia than DSM-II 
borderline schizophrenia and attributes this to an admixture of the two concepts in the 
minds of the original investigators in the Danish-American Adoption Study.1  These 8 
criteria were retained for DSM-IV with a ninth added to give the current definition of 
schizotypal personality disorder (Figure 1.1).  Similar criteria were used in ICD-9 and in 
ICD-10 although interestingly in the latter the “personality” label has been dropped, thus 
schizotypal disorder is classified in the same section as schizophrenia and other non-
affective, non-organic psychotic disorders.11   
 
In figure 1.1 one can see that schizotypal personality disorder includes features identified 
by the early writers such as eccentricity and a lack of close relationships, as well as 
attenuated positive symptoms such as ideas of reference, magical thinking and unusual 
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perceptual experiences.  This combination is a fairly close approximation of the modern 
usage of the term schizotypy although the attenuated positive symptoms are often 
regarded as more central to the diagnosis of schizotypal personality disorder (probably 
because they are often easier to elicit at clinical interview), an emphasis which is not 
inferred from the use of schizotypy.  It is therefore worth mentioning the other Cluster A 
personality disorders, with which schizotypal personality disorder overlaps, and which 
include features of schizotypy, i.e. paranoid personality disorder and schizoid personality 
disorder.   
  
A) A pervasive pattern of social and interpersonal deficits marked by acute discomfort with, and 
reduced capacity for, close relationships as well as by cognitive or perceptual distortions and 
eccentricities of behaviour, beginning by early adulthood and present in a variety of contexts, as 
indicated by five (or more) of the following: 
1) ideas of reference (excluding delusions of reference) 
 2) odd beliefs or magical thinking that influences behaviour and is inconsistent with subcultural  
      norms 
3) unusual perceptual experiences, including bodily illusions 
4) odd thinking and speech (eg. vague, circumstantial, metaphorical, overelaborate or stereotyped) 
5) suspiciousness or paranoid ideation 
6) inappropriate or constricted affect 
7) behaviour or appearance that is odd, eccentric, or peculiar 
8) lack of close friends or confidants other than first-degree relatives 
9) excessive social anxiety that does not diminish with familiarity and tends to be associated with  
    paranoid fears rather than negative judgements about self 
 
B) Does not occur exclusively during the course of schizophrenia, a mood disorder with psychotic 
features, another psychotic disorder, or a pervasive developmental disorder and is not due to the 
direct physiological effects of a general medical condition 
Figure 1.1  




Paranoid and Schizoid Personality Disorders 
Paranoid personality disorder shares a sense of suspicious mistrust with schizotypal 
personality disorder whereas schizoid personality disorder emphasises the significant 
detachment from social relationships and a restricted emotions (Figure 1.2 and 1.3 
respectively).  In DSM-II the term schizoid was used broadly and included some 
individuals with schizotypal features and some with other problems of intimacy and 
affection.  With the development of DSM-III those with schizotypal personality disorder 
were separated off, the term avoidant personality disorder was introduced to describe 
those social difficulties with a more obviously neurotic basis and the diagnostic criteria 
for schizoid personality disorder were narrowed so that it became more closely 
reminiscent of its original meaning.  The modern criteria for schizoid personality disorder 
closely resemble the autistic withdrawal and anhedonia central to the early descriptions of 
the relatives of schizophrenics and are given more prominence in the modern usage of 
schizotypy than they are in the clinical diagnostic criteria for schizotypal personality 
disorder.  Thus the inclusion of the characteristics of schizoid personality disorder under 
the umbrella of schizotypy helps to emphasise the importance of these social and 









A) A pervasive mistrust and suspiciousness of others such that their motives are interpreted as 
malevolent, beginning in early adulthood and present in a variety of contexts, as indicated by four 
(or more ) of the following 
 
1) suspects, without sufficient basis, that others are exploiting, harming or deceiving him or her 
2) is preoccupied with unjustified doubts about the loyalty of associates 
3) is reluctant to confide in others because of unwarranted fear that the information will be used     
    maliciously against him or her 
4) reads hidden, demeaning or threatening meanings into benign remarks/events 
5) persistently bears grudges, i.e. is unforgiving of insults, injuries or slights 
6) perceives attacks on his or her character or reputation that are not apparent to others and is  
    quick to react angrily or to counterattack 
7) has recurrent suspicions, without justification, regarding fidelity of spouse or partner 
 
B)  Does not occur exclusively during the course of schizophrenia, a mood disorder 
with psychotic features, or another psychotic disorder and is not due to the direct physiological 
effects of a general medical condition 
Figure 1.2 
DSM-IV criteria for paranoid personality disorders 
 
A) A pervasive pattern of detachment from social relationships and a restricted range of expression of 
emotions in interpersonal settings, beginning by early adulthood and present in a variety of 
contexts, as indicated by four (or more) of the following: 
1) neither desires nor enjoys close relationships, including being part of a family 
2) almost always chooses solitary activities 
3) has little, if any, interest in having sexual experiences with another person 
4) takes pleasure in few, if any, activities 
5) lacks close friends or confidants other than first degree relatives 
6) appears indifferent to the praise or criticism of others 
7) emotional coldness, detachment or flattened affectivity 
 
B)  Does not occur exclusively during the course of schizophrenia, a mood disorder 
with psychotic features, another psychotic disorder, or a pervasive developmental disorder and is 
not due to the direct physiological effects of a general medical condition 
Figure 1.3 
DSM IV diagnostic criteria for schizoid personality disorder 
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1.3  Summary of Clinical Features of Schizotypy 
A useful summary of the important characteristics of schizotypy is provided by those 
features examined in Kendler’s Structured Interview for Schizotypy (particularly as this 
is the rating scale which is used later in this report).  These are social isolation and 
introversion, oversensitivity, social anxiety, ideas of reference, suspiciousness, restricted 
emotion, magical thinking, illusions, psychotic-like symptoms, 
derealisation/depersonalisation, irritability and impulsivity as well as the clinical 
impression at interview of rapport, affect, organisation of speech/thought, odd/eccentric 
behaviour and suspiciousness.  As we have seen these features are represented among the 
three cluster A personality disorders discussed above but are not fully captured by any 















1.4  History of Autism and Pervasive Developmental Disorders 
 
The word autism is derived from the Greek “autos” meaning self and was first used by 
Bleuler in his description of schizophrenic individuals to describe an extreme narrowing 
of relationships and withdrawal into the self.3  It continued to be used by early writers on 
schizophrenia and it was not until 1943 that it was first applied to describe the disorder 
that we now perceive as autism when Leo Kanner published his seminal case series of 11 
children with what he described as “autistic disturbances of affective contact.”12  The 
characteristic features he described were a profound lack of affective contact with others; 
disturbances in communication (3 of the 11 children were mute); an insistent desire for 
sameness; a fascination with inanimate objects; high levels of certain skills such as 
memory, but major difficulties in other cognitive domains; and an attractive appearance.  
His clinical descriptions have stood the test of time and by and large are very similar to 
the modern day diagnostic criteria for autism, in particular the social difficulties, 
resistance to change of routine and language impairment (Figure 1.4).  Less robust were 
the assertions he made over the following years implicating a lack of maternal affection 
as the cause of autism, although he would have been strongly influenced by the 
predominance of psychoanalytic theories at the time.   
 
The following year, and apparently unaware of Kanner's report, Hans Asperger published 
his observations of 4 boys which he described as suffering from “autistic psychopathy.”13  
In the main Asperger’s patients presented with very similar clinical features to Kanner’s 
but they did not display the same degree of language impairment.  Asperger’s paper, 
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written in German, was largely ignored until 1981 when it was “rediscovered” by Lorna 
Wing who proposed the diagnosis of Asperger syndrome to describe those children who 
possessed the characteristic social impairments of autism but who possessed normal 
language abilities.14     
 
Kanner’s description of autism was initially intended to be a narrow diagnostic concept 
describing a rare disorder.  However, in the years following the publication of his original 
paper it was expanded to include many people with intellectual impairment or brain 
damage and isolated autistic symptoms.  In addition, autism was felt to be part of 
childhood schizophrenia and the combination of these factors led to a rather wider 
concept of the disorder than Kanner intended.15  Studies by Kolvin in the 1960s and 70s 
which distinguished autism from childhood schizophrenia in terms of age of onset, 
course, phenomenology and family history16 helped to narrow the concept again.  
However in the 1980s it began to re-expand albeit in a different direction with Wing’s 
description of Asperger syndrome.14  This has led to current ideas of the autism spectrum 
where manifestations of autism can vary from mild to severe.  Certainly the symptoms 
displayed in Asperger syndrome are such that it appears to be a mild form of autism 







1.5  Clinical Symptoms and Diagnostic Criteria of Pervasive Developmental 
Disorders 
 
In both DSM-IV and ICD-10 autism and Asperger syndrome are classified together under 
the rubric of pervasive developmental disorders (PDD).  The diagnostic criteria for each 
are shown in Figures 1.4 and 1.5.  In addition there are a number of other PDDs, the 
places of which in relation to the autistic spectrum are unclear.  Rett’s Disorder has been 
reported only in females (males with the disorder are thought to die in utero) and is 
characterised by a period of normal development followed by the development of 
multiple specific deficits including motor skills, social engagement and language.  
Childhood Disintegrative Disorder is defined by a period of normal development which 
can be up to 10 years long, followed by a rapid regression of previously acquired social 
and language skills and loss of motor skills and bowel and bladder control.  Finally the 
diagnosis of non-specific pervasive developmental disorder (PDD-NOS) can be given 
when there is significant impairment of social interactions or stereotyped behaviours are 
present but the diagnostic criteria for other PDDs are not met.   An example of this is 
atypical autism which includes “presentations which do not meet the criteria for autism 
because of late age of onset, atypical symptomatology or subthreshold 
symptomatology.”19  Generally speaking, the autism spectrum is usually regarded as 
including autism and Asperger syndrome, with Rett’s Disorder and Childhood 






A) A total of six (or more) items from 1, 2, and 3 with at least two from 1, and one each from 2 and 3: 
1) qualitative impairment in social interaction, as manifested by at least two of the       
     following: 
a) marked impairment in the use of multiple nonverbal behaviours, such as eye-to- eye    
    gaze, facial expression, body postures, and gestures to regulate social interaction  
b) failure to develop peer relationships appropriate to developmental level  
c) a lack of spontaneous seeking to share enjoyment, interests, or achievements with  
    other people (e.g., by a lack of showing, bringing, or pointing out objects of interest)  
d) lack of social or emotional reciprocity  
2) qualitative impairments in communication, as manifested by at least one of the    
    following:  
a) delay in, or total lack of, the development of spoken language (not accompanied by an  
    attempt to compensate through alternative modes of communication such as gesture or     
    mime)  
b) in individuals with adequate speech, marked impairment in the ability to initiate or  
    sustain a conversation with others  
c) stereotyped and repetitive use of language or idiosyncratic language  
d) lack of varied, spontaneous make-believe play or social imitative play appropriate to   
    developmental level 
3) restricted, repetitive, and stereotyped patterns of behaviour, interests, and activities as  
    manifested by at least one of the following:  
a) encompassing preoccupation with one or more stereotyped and restricted patterns of  
    interest that is abnormal either in intensity or focus  
b) apparently inflexible adherence to specific, non-functional routines or rituals  
c) stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting  
    or complex whole-body movements)  
d) persistent preoccupation with parts of objects  
B) Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3 
years: social interaction; language as used in social communication; or symbolic or imaginative 
play.  
C) The disturbance is not better accounted for by Rett's disorder or childhood disintegrative disorder.  
Figure 1.4 






A) Qualitative impairment in social interaction, as manifested by at least two of the following: 
1) marked impairment in the use of multiple nonverbal behaviours, such as eye-to-eye gaze, facial  
    expression, body postures, and gestures to regulate social interaction  
2) failure to develop peer relationships appropriate to developmental level  
3) a lack of spontaneous seeking to share enjoyment, interests, or achievements with other people  
    (e.g., by a lack of showing, bringing, or pointing out objects of interest to other people)  
4) lack of social or emotional reciprocity  
 
B) Restricted, repetitive, and stereotyped patterns of behaviour, interests, and activities, as manifested 
by at least one of the following:  
1) encompassing preoccupation with one or more stereotyped and restricted patterns of interest  
    that is abnormal either in intensity or focus  
2) apparently inflexible adherence to specific, non-functional routines or rituals  
3) stereotyped and repetitive motor mannerisms (e.g., hand or finger flapping or twisting, or  
    complex whole-body movements)  
4) persistent preoccupation with parts of objects  
 
C) The disturbance causes clinically significant impairment in social, occupational, or other important 
areas of functioning.  
D) There is no clinically significant general delay in language (e.g., single words used by age 2 years, 
communicative phrases used by age 3 years).  
E)  There is no clinically significant delay in cognitive development or in the development of age-
appropriate self-help skills, adaptive behavior (other than in social interaction), and curiosity about 
the environment in childhood.  
F) Criteria are not met for another specific pervasive developmental disorder or schizophrenia.  
Figure 1.5 








1.6  Clinical and Neuropsychological Overlaps Between Pervasive Developmental 
Disorders and Schizotypy 
 
As mentioned above, autism and schizophrenia have been regarded as separate disorders 
since the work of Kolvin on the early 1970s.16  However there is no doubt that similarities 
between the disorders do exist particularly with respect to the negative symptoms of 
schizophrenia.  In a study of 21 individuals with chronic, treatment resistant 
schizophrenia Sheitman et al found that autistic features as measured by the Autism 
Behaviour Checklist correlated with the degree of negative but not positive symptoms.20  
Examining the issue from the opposite direction Konstantareas et al found that 50% of 
autistic individuals met diagnostic criteria for schizophrenia, disorganised type with 
negative symptoms.21  In a direct comparison of autism and schizophrenia the autistic 
subjects were found to have significantly less positive thought disorder than 
schizophrenic subjects but with no difference in measures of affective flattening.22  These 
findings indicate that negative symptoms are shared between the disorders but that 
autistic individuals do not show the same degree of positive symptomatology as is found 
in schizophrenia.  It is important to note the possibility that negative symptoms of 
schizophrenia and autistic features are different phenomena which are simply difficult to 
distinguish clinically, but it is equally possible that they represent the same underlying 
pathophysiogical process.   
 
There is some evidence that similar neuropsychological deficits are seen in autism and 
schizophrenia.  A reduction in the capacity to perform Theory of Mind tasks (the ability 
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to infer mental states in others), although not part of the diagnostic criteria is a well 
documented feature of autism and Asperger syndrome and is thought to be central to 
many of the social deficits seen in these disorders.23  Theory of Mind deficits have also 
been reported in schizophrenia24 and in the relatives of individuals with schizophrenia25 
suggesting that a similar process may underlie the social deficits observed in both 
schizophrenia and PDD.  In addition, faulty theory of mind processing has been proposed 
as central to the genesis of delusional ideation in schizophrenia.26  Executive function 
deficits have also been reported in both schizophrenia and PDD.27,28  People with PDD 
have also been found to have a preference for local over global processing, i.e. they focus 
more on detail rather than surrounding contextual information (decreased central 
coherence).29  Studies of local-global processing in schizophrenia are equivocal with 
some reporting a preference for global processing while others report the opposite.30,31 
 
There are few neuropsychological studies which have directly compared autism and 
schizophrenia and certainly too few to draw firm conclusions from.  In general they tend 
to show both similarities and differences between schizophrenia and autism with respect 
to neuropsychological testing.  Individuals with autism have been found to perform less 
well at tasks of recognising basic facial emotions than people with schizophrenia or their 
first degree relatives32 and in addition, discrimination of autism from schizophrenia on 2 
of the 11 subtests of the Weschler Intelligence Scales has also been reported in the same 
population.33  Schneider reported similarities between autism and schizophrenia in digit 
symbol substitution and differences in a receptive language task and performance on the 
Wisconsin Card Sorting Test.34  Goldstein et al used cluster analysis of scores on a 
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variety of neuropsychological tests covering general intelligence and executive function 
to divide a population of schizophrenic individuals into 4 sub-groups and compared these 
with a group of individuals with high-functioning autism.  They found that one of the 
sub-groups of schizophrenic individuals displayed a similar neuropsychological profile to 
people with high functioning autism whereas the others did not.35  Unfortunately there are 
no studies which compare mentalising abilities or central coherence (local-global 
processing between autism and schizophrenia.   
 
Turning to schizotypy, it is clear even from a quick inspection of the DSM-IV criteria 
that there are clinical overlaps between pervasive developmental disorders and 
schizoid/schizotypal personality disorders.  Social withdrawal and a preference for 
solitary activities along with a lack of affective expression and diminished social 
reciprocity are all features which are common to both sets of disorders.  Further overlaps 
become obvious when one considers the psychiatric symptoms known to occur in PDD 
but which do not form part of the diagnostic criteria.  Neurotic symptoms are especially 
common but high rates of delusional ideas have also been reported in particular 
persecutory and grandiose delusions.36  Thought disorder, similar to that seen in 
schizophrenia, has also been reported in a study of autistic adolescents and adults.37  It is 
not surprising therefore that 23.4% and 31.9% of patients with an autism spectrum 
disorder have been found to meet criteria for schizotypal and schizoid personality 
disorder respectively (compared with 4.9% and 12.3% of people with attention deficit 
hyperactivity disorder).38  Additionally, in a survey of consultant child and adolescent 
psychiatrists in London the three most common features in adolescents suspected of 
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having a diagnosis of schizotypal personality disorder were odd behaviour, a lack of close 
friends and inappropriate or constricted affect, all features which could easily be confused 
with PDD.39   
 
This overlap of diagnostic categories was considered in great detail by Sula Wolff who 
over the course of 30 years described a group of 149 children who she labelled as 
suffering from “schizoid personality disorder of childhood.”  It should be noted that at the 
time this diagnostic label was given the term schizoid personality disorder was used 
differently to how it is today and would have encompassed both the modern day schizoid 
and schizotypal personality disorders - Wolff herself later commented that in modern 
criteria a diagnosis of “schizotypal personality disorder” or “cluster A personality 
disorder” of childhood would actually be more correct.  These children were generally 
referred for “marked difficulty in social adjustment at school” and are described as being 
solitary and sensitive (about themselves, not others) with occasional paranoid ideas; 
lacking empathy; possessing rigid preoccupations with their own interests; using odd 
metaphorical language and having unusual fantasy lives.  Following Wing’s description 
of Asperger syndrome Wolff noted that many of her own case series shared features of 
and would likely have met diagnostic criteria for Asperger syndrome (although appears 
never to have formally tested this).40  She later suggested that the correct diagnostic label 
for such children should be “schizoid/Asperger disorder.”41  In ICD-10 schizoid 
personality disorder of childhood is included under Asperger syndrome.11  Notably 
however, of the 149 children Wolff studied with schizoid personality disorder of 
childhood 5% were found to have developed schizophrenia in adulthood compared to 
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0.7% of control children.41  Additionally in a subset of 32 of the schizoid children 
diagnostic continuity was demonstrated with schizotypal personality disorder in 
adulthood in 24 subjects (75%).  There are other case studies which have also reported 
individuals who attracted a diagnosis of PDD as children but later went on to develop 
schizophrenia42,43 and Sporn et al report that 25% of the children they studied with 
childhood onset schizophrenia had an initial diagnosis of autism spectrum disorder.44  In 
addition, a recent family study which examined the prevalence of psychiatric illness in 
first degree relatives of people with Asperger syndrome found a substantially higher rate 
of schizophrenia (15%) than is present in the general population.45  It is interesting that 
this relationship is not seen in family history studies of people with autism.46   
 
Findings from the above studies raise two possibilities.  The first is that the autism 
spectrum and the schizophrenia spectrum show clinical and neuropsychological overlaps 
but are distinct unrelated disorders.  In this model the conversion from childhood PDD to 
adulthood psychosis and the increased prevalence of schizophrenia in first degree 
relatives of individuals with Asperger syndrome may relate to the misdiagnosis of 
schizotypal features as autistic ones.  It should also be considered within this model that 
childhood PDD may be a non-specific vulnerability factor for the development of a later, 
unrelated psychotic illness (e.g. through increasing childhood adversity) although this 
would not explain the increased prevalence of schizophrenia in first-degree relatives of 
people with Asperger syndrome.  The second possibility is that pervasive developmental 
disorders and schizophrenia spectrum disorders are related, overlapping disorders which 
share not only clinical features but also have common aetiological and/or 
20 
 
pathophysiological mechanisms.  It is hoped that by examing the brain structure which 
underlies PDD and schizotypy this thesis may begin to elucidate the nature of the 




























Literature Review of Structural MRI Studies of Schizotypy 
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2.1  Introduction 
 
Given the known clinical and familial relationships between schizotypy and 
schizophrenia it is not unreasonable to propose that the former will show similar 
aetiological and pathophysiological mechanisms to the latter.  There must however be an 
underlying reason (or reasons) why individuals with schizotypy do not display the more 
severe phenotype of schizophrenia.  The investigation of brain structural abnormalities in 
schizotypy may therefore lead to a greater understanding of why some individuals 
progress to schizophrenia while others do not.  Despite this there is a paucity of 
neuroimaging research which concerns schizotypy relative to the number of studies 
whichi examine schizophrenia.  In those studies which do exist a variety of approaches 
have been adopted and this review is structured to reflect this.  The majority of 
researchers have chosen to study schizotypal personality disorder (SPD), hence these are 
considered first.  A second approach has been to use psychometric rating scales to 
measure schizotypal features and correlate these features with brain structure.  Finally 
there are studies which examine unaffected family members of schizophrenic individuals.  
These are included here where there is some measure of schizotypy or psychotic 
symptomatology on which the relatives score more highly than controls.  Studies of ultra 
high risk individuals have not been included, despite the prominence of schizotypal 
features in such groups, due to the high rates of progression to schizophrenia within a 
year (about 30%)47 suggesting that many of these individuals are prodromal for 







Medline, EMBASE and PsychINFO were searched for all English language studies 
published between January 1984 and March 2006 that reported structural MRI data in 
people with autism and unaffected controls.  The search terms were “magnetic resonance 
imaging” combined using the AND operator with “schizotypal”, “schizotypy”, 
“schizoid”, “schizophrenia spectrum” or combinations of both “schizophrenia” and one 
of “sibling”, “twin”, “offspring” “child”, “progeny”, “relative”, “family” or “high risk” 
and related terms.  Both free-text and expanded medical subject headings were used.  
Subject headings were adapted to the specific subject headings of the biomedical 
databases used.  The search strategy was supplemented by including a cited reference 
search and inspecting the reference lists of included articles.   
 
Criteria for inclusion 
All abstracts were independently assessed for inclusion by two people (including the 
author), and articles in full text were retrieved if appropriate.  Full text articles were then 
inspected independently by the same individuals.  Any disagreements at either stage were 
resolved by discussion.   
 
Primary research studies were considered for inclusion if they were published as a peer-
reviewed article in English and compared subjects with schizotypy and a group of healthy 
controls or examined continuous relationships of schizotypal features with brain 
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structure.  As detailed above these were divided into three groups: studies of subjects 
with a schizophrenia spectrum personality disorder (schizoid, schizotypal or paranoid 
personality disorder); correlation studies of schizotypal features and brain structure and 
studies of subjects with a family history of schizophrenia and features of schizotypy 
although without a formal diagnosis.  Studies which reported data on schizotypal 























1053 articles were identified through the database search of which 163 were reviewed in 
full text.  Of these 31 articles were suitable for the review: 24 concerned a schizophrenia 
spectrum personality disorder, 3 were correlational analyses of schizotypal features and 4 
concerned individuals with a family history of schizophrenia who displayed features of 
schizotypy.  Of the excluded articles 111 did not concern schizotypy, 8 were review 
articles, 5 were not structural MRI studies, 5 were not written in English and 3 contained 
no quantitative data.  The articles included in the review are shown in Table 2.1.   
 
Schizotypal Personality Disorder 
 
Whole Brain and Intracranial Volume   
Three studies have reported on the total brain volume in SPD, none of which found any 
significant difference between SPD and controls.48-50  Similarly three studies have 
examined total intracranial volume and again report no difference in results.51-53 
 
Total Cerebral Hemispheres 
Suzuki et al found no difference between the SPD group and normal controls although 
the SPD group did have larger grey matter than subjects with schizophrenia.54  A trend 
towards a reduction in cortical grey matter in SPD versus controls was found by Dickey 
et al although this did not reach statistical significance.51  Neither study found any 
significant changes in cerebral white matter.   
 
  Schizotypal Subjects Schizophrenia Subjects 
Controls / Non-
schizotypal subjects   













s Main Findings 
*Buchsbaum 
(1997)55 DSM-IV SPD 12 (11:1) 45.8 11 (10:1) 42.9 23 (21:2) 45.2 tbv 
Enlarged lateral ventricles in SCZ compared 
to SPD and controls 
No difference between SPD and controls 
although tended to lie intermediate between 
controls and SCZ in temporal horn but not 
anterior horn or body 
No difference in total brain volume.  
Reduced pulvinar in schizotypal and 
schizophrenia group.  No difference in 
mediodorsal nucleus 
*Byne 
(2001)56 DSM-IV SPD 12 (11:1) 42.7 12 (11:1) 43.7 12 (11:1) 42.2 tbv 
**Dickey 
(1999)57 DSM-IV SPD 16 (16:0) 39.9 N/A N/A 14 (14:0) 38.2 icv 
Reduction in left superior temporal gyrus 
and reversed asymmetry in 
parahippocampal gyrus in SPD 
No differences in amygdala or hippocampus 
**Dickey 
(2000)51 DSM-IV SPD 16 (16:0) 39.9 N/A N/A 14 (14:0) 38.2 icv 




DSM-IV SPD 21 (21:0) 38.0 N/A N/A 22 (22:0) 38.4 icv 
Smaller left Heschl’s gyrus in SPD 
No difference in right Heschl’s gyrus or 
bilateral planum temporale 
**Dickey 
(2003a)48 DSM-IV SPD 21 (21:0) 37.1 N/A N/A 19 (19:0) 38.4 icv No difference in fusiform gyrus 
Dickey 
(2003b)59 DSM-IV SPD 21 (0:21) 28.4 N/A N/A 29 (0:29) 30.4 icv No difference in superior temporal gyrus 
*Downhill 
(2000)60 DSM-IV SPD 13 (12:1) 43.3 27 (20:7) 38.3 31 (23:8) 41.2 tbv Increased anterior corpus callosum in SPD. 
*Downhill 
(2001)61 DSM-IV SPD 13 (12:1) 43.3 27 (20:7) 38.3 31 (23:8) 41.2 tbv 
Equally reduced temporal lobe grey matter 
(both in superior temporal gyrus and in 
remainder of lobe) in SPD and 
schizophrenia relative to controls.  No 
differences in temporal lobe white matter 
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No significant differences in thalamus or 
whole brain volume *Hazlett (1999)49 
DSM-IV SPD 13 (12:1) 43.3 27 (20:7) 38.3 32 (25:7) 41.8 tbv 
*Haznedar 
(2004)62 DSM-IV SPD 13 (12:1) 43.3 27 (20:7) 38.3 32 (25:7) 41.8 tbv No significant differences in cingulate gyrus 
†Job (2005)63 
Relatives with 
transient or partial 
psychotic symptoms 
on PSE compared to 
relatives without 
18 (-) - N/A N/A 47 (27:20) 23.2 - 
Reduction over time in left temporal lobe 
grey matter greater in symptomatic relatives 
than non-symptomatic ones 
††Kawasaki 
(2004)64 DSM-IV SPD 25 (14:11) 25.0 25 (14:11) 25.8 50 (28:22) 24.0 - 
VBM study.  Frontotemporal reductions in 
schizophrenia and SPD although less 




Offspring with high 
scores on magical 
ideation-perceptual 
aberration scales 
compared to normal 
controls 
17 (8:9) 15.6 N/A N/A 22 (11:11) 14.6 icv 
Smaller left amygdalo-hippocampal 
complex in offspring of schizophrenics 
compared to normal controls.  No difference 
in right amygdalo-hippocampal complex or 
dorsolateral prefrontal cortex 
Koo (2006)52 DSM-IV SPD 32 (0:32) 30.0 N/A N/A 29 (0:29) 32.0 icv 
Reduced caudate bilaterally in SPD 
associated with increased positive and 
negative symptoms and deficits in executive 




transient or partial 
psychotic symptoms 
on PSE compared to 
relatives without 
41 (19:22) 21.2 N/A N/A 101 (54:47) 21.1 tbv 
Reduced whole brain in symptomatic 
subjects.  No differences in prefrontal and 





transient or partial 
psychotic symptoms 
on PSE compared to 
relatives without 
19 (7:12) 23.0 N/A N/A 47 (27:20) 23.2 - 
Reduction over time in right temporal lobe 
greater in symptomatic relatives than non-
symptomatic ones. 
Reduced caudate bilaterally in SPD 
associated with increased perseverative 
errors in working memory tasks 
**Levitt 





DSM-IV SPD 15 (15:0) 38.5 N/A N/A 14 (14:0) 38.0 - Study of shape differences Higher caudate head in SPD 
‡Matsui 
(2000)70 
MMPI N/A N/A N/A N/A 59 (29:30) 26.8 icv 
Normal population correlation study. 
Negative correlation between frontal lobe 
volume and anhedonia, paranoia and 




subscales (high and 
low) 
N/A N/A N/A N/A 42 (22:20) 20.3 - 
Normal population correlation study. 
Correlation between lack of self control and 







N/A N/A N/A N/A 17 (8:9) 33.9 - 
Normal population correlation study. 
High schizotypal scores correlate with 
reduced prefrontal volume 
Raine (2002)50 DSM-IV SPD (10), PPD (4) and both (2) 16 (14:2) 30.9 N/A N/A 27 (23:4) 32.1  
Reduced prefrontal volume which was non-
significant once antisocial personality 
disorder controlled for.  No difference in 
whole brain volume 
No difference in caudate volume.  Reduced 
putamen in SPD and larger putamen in 
schizophrenia relative to controls 
*Shihabuddin 
(2001)73 DSM-IIIR SPD 16 (15:1) 43.3 42 (30:12) 37.8 47 (35:12) 38.3 icv 
††Suzuki 
(2004)74 DSM-IV SPD 24 (13:11) 24.9 N/A N/A 47 (25:22) 25.1 age, icv 
Decreased right anterior limb of internal 
capsule in SPD.  No difference in caudate or 
lentiform volumes 
Equally reduced amygdala and 
hippocampus in both SPD and 
schizophrenia relative to controls.  No 
differences in parahippocampal gyrus.  
Increased middle frontal gyrus and reduced 
right straight gyrus in SPD compared to 
controls.  Increased right superior and 
inferior frontal gyrus and bilateral middle 




ICD-10 SD, DSM 




(2002)75 ICD-10 SD 24 (12:12) 22.7 40 (20:20) 26.2 48 (24:24) 24.2 
age, icv, 
gender 
No difference in anterior cingulate gyrus in 




Table 2.1   
Structural MRI studies of schizotypy included in the review 
DSM-IV - Diagnostic and Statistical Manual; ICD-10 – International Classification of Diseases; MMPI – Minnesota Multiphasic 
Personality Inventory; SPD – schizotypal personality disorder, SD – schizotypal disorder, - - no data available, N/A – not applicable, 
icv – intracranial volume, tbv – total brain volume   
*, **, †, ††, ‡, ‡‡ - overlapping populations 
††Takahashi 





No difference in perigenual gyrus size.  
Lack of normal gender differences in SPD 
and schizophrenia 
††Takahashi 




No difference in short or long insular 
cortices between SPD and controls.  
Reduced in schizophrenia. 
Equally reduced left planum temporale and 
superior temporal gyrus in SPD and 
schizophrenia relative to controls. Reduced 
Heschl’s gyrus in schizophrenia but not 
SPD relative to controls. No differences in 
planum polare. 
††Takahashi 





(2003)78 ICD-10 SD, MMPI 14 (5:9) 24.5 N/A N/A 28 23.4 - 
VBM study.  Reduced grey matter in 
bilateral insula and left entorhinal cortex 
 
Frontal Lobe 
In a group of individuals with a mixture of paranoid personality disorder and SPD Raine 
et al found reductions in prefrontal grey matter volume which was associated with poorer 
performance on frontal lobe tasks.  This difference was abolished when antisocial traits 
were controlled for.50  Suzuki et al found differences in regional prefrontal areas between 
individuals with SPD, schizophrenia and normal controls.  Specifically the SPD group 
had larger volumes of the middle frontal gyrus bilaterally and smaller volumes of the 
right straight gyrus than the normal controls.  In addition subjects with SPD had larger 
right superior, right inferior and bilateral middle frontal gyri than the schizophrenia 
group.54   
 
Temporal Lobe Structures 
The studies which examined the temporal lobe and its subregions are shown in Table 2.2.  
The findings are conflicting but on balance suggest that the temporal lobe is affected in 
schizotypal personality disorder.  Three studies report reductions in the superior temporal 
gyrus,53,57,61 while one found no difference.59  The negative study concerned only females 
while the others concerned males or mixed groups suggesting that females with SPD may 
have different neuroanatomical features to males.  Other findings were more equivocal 
with positive and negative findings reported in one study each for the amygdala, 








Takahashi et al report a lack of right greater than left asymmetry in the anterior cingulate 
gyrus of female patients with SPD compared to normal controls with similar findings 
being seen in schizophrenia.  No differences in the overall size of the anterior cingulate 
gyrus were seen.75  In a separate study of the perigenual cingulate gyrus the same authors 
report no difference between SPD patients and either normal controls or schizophrenics 
although a lack of difference between genders which was seen in the normal controls.76  
Haznedar et al found no difference between SPD and controls in any part of the cingulate 
gyrus.62   
 
Thalamus 
Hazlett et al found that there were no differences in the total thalamic volume between 
individuals with SPD, schizophrenia and normal controls.49  In a subset of this group 
Byne et al found the size of the pulvinar was reduced in both schizophrenia and SPD 
relative to controls, whereas the mediodorsal nucleus did not differ between the groups.56   
 
Basal Ganglia 
Studies which examined the basal ganglia are somewhat equivocal with 2 studies from 
the same group reporting reductions in caudate volume (one in males and one in 
females)52,68 while 2 others report no difference between individuals with SPD and 
controls.73,74  Additionally Shihabuddin et al found a reduction in the volume of the 
putamen in SPD relative to controls73 whereas Suzuki et al found no difference in the size 




Studies of temporal lobe structures in SPD 
Abbreviations as in Table 2.1.  
 Schizotypal Subjects Schizophrenia Subjects Controls   
Study (year) N Mean / median age N 
Mean / 
median age N 
Mean / 
median age Covariates Main Findings 
*Dickey 
(1999)57 16 (16:0) 38.2 N/A N/A 14 39.9 icv 
Reduction in left superior temporal gyrus 
and reversed asymmetry in 
parahippocampal gyrus in SPD 




21 (21:0) 38.0 N/A N/A 22 (22:0) 38.4 icv 
Smaller left Heschl’s gyrus in SPD 
No difference in right Heschl’s gyrus or 
bilateral planum temporale 
*Dickey 
(2003a)59 21 (21:0) 37.1 N/A N/A 19 (19:0) 38.4 icv No difference in fusiform gyrus 
*Dickey 
(2003b)59 21 (0:21) 28.4 N/A N/A 29 (0:29) 30.4 icv No difference in superior temporal gyrus 
Downhill 
(2001)61 13 (12:1) 43.3 27 (20:7) 38.3 31 (23:8) 41.2 wbv 
Equally reduced temporal lobe grey 
matter (both in superior temporal gyrus 
and in remainder of lobe) in SPD and 
schizophrenia relative to controls.  No 




(15:10) 25.5 53 (32:21) 25.3 59 (35:24) 24.3 
age, icv, 
gender 
Equally reduced amygdala and 
hippocampus in both SPD and 
schizophrenia relative to controls.  No 








Equally reduced left planum temporale 
and superior temporal gyrus in SPD and 
schizophrenia relative to controls. 
Reduced Heschl’s gyrus in schizophrenia 
but not SPD relative to controls. No 
differences in planum polare. 
 
Corpus Callosum 
Only one study examined the corpus callosum in SPD and reported enlargements of the 
anterior corpus callosum relative to normal controls.  This is in contrast to patients with 
schizophrenia who were found to have reductions in the same region.  The posterior 
callosum was found to be significantly reduced in schizophrenia and non-significantly 
reduced in SPD compared to controls.60   
 
Lateral ventricles 
Two studies examined the lateral ventricles in SPD.51,55  Buchsbaum et al compared 
lateral ventricle volumes between individuals with schizotypal personality disorder, 
schizophrenia and normal controls.  They found significant increases in the body of the 
lateral ventricle in schizophrenia compared to the subjects with SPD and normal controls.  
No significant differences were found between the SPD subjects and the controls, 
although for the temporal horn the SPD group tended to lie between the schizophrenia 
group and the controls.55  In contrast Dickey et al found that the CSF volume was larger 
in SPD than in controls but that this was not attributable to ventricular volume.51     
 
Other intracerebral areas 
Suzuki et al report a reduction in the volume of the right anterior limb of the internal 
capsule in SPD compared to normal controls.74  The same group also report reductions in 
the anterior and posterior insular cortices in schizophrenia compared to SPD and normal 




VBM Studies of Schizotypal Personality Disorder 
There have been only two VBM studies of SPD, both from the same group.  In an attempt 
to delineate a homogenous group of schizotypal individuals Yoneyama examined a group 
of patients who not only met diagnostic criteria for SPD but also scored highly on 
schizophrenia related code types on the Minnesota Multiphasic Personality Inventory 
(MMPI).  They found decreased grey matter in the insular regions bilaterally and in the 
left entorhinal cortex compared to controls.78  Kawasaki et al used VBM to look for 
differences between patients with SPD, those with schizophrenia and normal controls.  
The schizophrenia patients showed widespread frontotemporal reductions in grey matter 
compared to controls.  The SPD group shared reductions in grey matter with the 
schizophrenia group in the left inferior frontal gyrus, insula, superior temporal and medial 
temporal gyri, although were less severely affected overall, particularly in the frontal 
lobe.   
 
Studies utilising schizotypy rating scales 
Raine et al examined the relationship between schizotypy and prefrontal lobe size in a 
group of 17 people using three rating scales - STA, Schizophrenism and Social 
Anhedonia.  The first two measure positive symptoms of schizotypy while the third 
measures negative features.  Higher levels of schizotypy were found to correlate 
significantly with reduced prefrontal lobe size, however major limitations of this study 
are the low field strength of the MRI scanner (0.15 Tesla) and the use of a single coronal 
slice to estimate prefrontal lobe size.72  Similarly Matsui et al found that reduced frontal 
lobe volume correlated with schizophrenia related subscales in a non-clinical 
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population.70  In a separate population the same group used VBM to look for grey matter 
correlations with scores on schizophrenia related subscales of the MMPI and found that 
lack of self control was related to reduced grey matter density in the supplementary motor 
cortex.71   
 
Studies examining relatives of individuals with schizophrenia which have included an 
indication of schizotypal features 
While there are many studies of relatives of individuals with schizophrenia only four 
gave any clear indication of the presence of schizotypal features.  Three of these are from 
the EHRS where the features in question were the presence of transient or isolated 
psychotic symptoms, and one is from the Pittsburgh high risk study in which the relatives 
score more highly on scales of magical ideation and perceptual aberration.  In the EHRS 
symptomatic subjects had significantly smaller brains than subjects without symptoms 
although there was a trend towards enlargement of the right prefrontal lobe and temporal 
lobes relative to the whole brain volume.66  Using region of interest methods 
symptomatic subjects showed significantly greater reductions in right temporal lobe 
volumes over time than those without symptoms in addition to non-significant right 
prefrontal reductions.67  Different changes over time were found in the same group using 
VBM, in that left temporal reductions occurred over time (as opposed to right).63  The 
Pittsburgh study found that the schizotypal offspring had a smaller left amygdala-








There is a general lack of research in this area compared to that on schizophrenia thus 
there is little replication of results and conclusions have to be drawn on limited data.  In 
addition the majority of research concerns individuals with schizotypal personality 
disorder thus may not be representative of the entire spectrum of schizotypy.  Although 
many studies examined relatives of people with schizophrenia few of these gave any 
information regarding schizotypal features which may be a missed opportunity.  The 
studies which were included used reliable diagnostic methods and groups were generally 
well matched for age and gender.  Possible confounders which were not often considered 
included IQ differences between subjects and controls, the presence of other psychiatric 
disorder in subjects and whether or not the schizotypal individuals had a family history of 
schizophrenia.   
 
Main Findings 
Despite the lack of available research it is possible to say that, in general, individuals 
with SPD share some but not all of the structural abnormalities which are present in 
schizophrenia.  The shared abnormalities mainly lie in the temporal lobe whereas the 
prefrontal region may be relatively spared compared to schizophrenia and even show sub-
regional enlargements relative to normal controls.  These findings have led to the 
suggestion that in SPD individuals the prefrontal lobe acts to buffer anatomical 
abnormalities of the temporal lobe thus providing protection from the development of 
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schizophrenia.79  This hypothesis must be balanced against the fact that in 
neuropsychological studies of schizotypy deficits in executive function are commonly 
seen.50  It is possible that the non-uniformity of the prefrontal lobe structural changes 
reported by Suzuki et al54 may account for this with some regions of the prefrontal lobe 
being relatively spared while others are not and functional imaging studies provide some 
evidence that this is indeed the case.  In a functional MRI (fMRI) study using a visuo-
spatial memory task Koenigsberg et al report decreased activation of the left prefrontal 
cortex with increased activation in the right middle frontal gyrus and prestriate cortex in 
schizotypal subjects relative to either normal controls or schizophrenic subjects,80 a result 
which is consistent with the structural MRI findings of Suzuki et al.54  Increased middle 
frontal gyrus activation during the Wisconsin Card Sorting Test (WCST - a widely used 
test of executive function) has also been reported using positron emission tomography 
(PET) in schizotypal individuals relative to normal controls.  This increase in activation 
corresponded with better performance on the WCST while increased inferior frontal 
gyrus activation correlated with worse performance.81  In a further PET study Buchsbaum 
et al report increased metabolic rates in Brodmann area 10 (BA10) in schizotypal 
individuals relative to normal controls.82  Interestingly in the EHRS, increased right 
prefrontal cortical folding was found to distinguish individuals who went on to develop 
schizophrenia from those who did not.  Increased right prefrontal volume was also 
reported in the same paper and it was the anterior middle frontal gyrus region in BA10 
which showed the greatest amount of sulcal branching on post hoc review of the scans.83  
The one existing diffusion tensor imaging study in schizotypal personality disorder is also 
supportive of the theory of non-uniform deficits in the prefrontal lobe, finding a reduction 
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in fronto-temporal connectivity via the uncinate fasiculus but preserved fronto-limbic 
connectivity via the cingulum bundle.84   
 
It is interesting to note that those studies which have examined normal populations have 
tended to show that increasing levels of schizotypy are associated with reduced prefrontal 
volume and have no relation with temporal lobe size.  This stands in contrast to the 
results for SPD and raises the possibility that different underlying pathophysiological 
mechanisms may be at work.  However there are only three such studies and 
interpretation is difficult as it is not clear whether any of the participants met criteria for 
SPD or whether they concerned only individuals with sub-diagnostic levels of 
schizotypal features.   
 
Conclusions  
It appears from the available literature that SPD is associated with temporal lobe 
structural abnormalities in a similar but less severe pattern as is seen in schizophrenia.  
These may in part be compensated for by a relatively intact frontal lobe thus preventing 
deterioration into schizophrenia.   It is possible that different pathophysiological 
mechanisms account for the presence of schizotypal features in the general population 
than in people with SPD.  These findings must be regarded as preliminary due to the lack 
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While early writers proposed that autism was caused by a lack of maternal 
responsiveness85 it is now widely accepted as neurodevelopmental in origin.  However, 
until relatively recently little was known about the brain structure associated with the 
disorder.  Increasingly sophisticated neuroimaging techniques have played a major role in 
the advancement of knowledge in this area, in particular the advent of magnetic 
resonance imaging (MRI) which has enabled researchers to examine the autistic brain in 
vivo in unprecedented degrees of detail.  Over the past 20 years there have been many 
MRI studies of the brain in autism and a wide variety of regions have been identified as 
structurally abnormal.  Unfortunately there is often disagreement between studies and the 
literature can appear contradictory.   
 
For example, hypoplasia of cerebellar vermal lobules VI-VII was one of the first 
structural abnormalities found to be associated with autism86 but while this finding has 
been replicated by some studies87 others have failed to find such an association.88,89  
Vermal hypoplasia has also been identified in other neurodevelopmental syndromes90 
leading some authors to suggest that it is a non-specific effect of IQ rather than related to 
autistic features per se.91  More recently interest has focused on the total brain volume in 
autism with some studies showing an enlargement 92 while others find no difference93 in 
size.  Several studies have reported that these differences are dependent on age with 
younger autistic subjects showing an enlargement that is not seen in their older 
counterparts.94,95  However the exact age at which this distinction can be seen varies 
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between studies and brain enlargement has been reported in adult autistic populations.96  
Results for other brain regions also show inconsistencies.  For example the amygdala has 
been variously reported to be enlarged,92 reduced97 or no different in size98 relative to 
controls and a similar spread of results has been seen for the hippocampus.92,98,99  One 
study found age dependent differences for the amygdala in a similar pattern to those 
reported for total brain volume although such a relationship was not seen for the 
hippocampus.100 
 
Several reviewers have sought to draw together this literature qualitatively101, 102 however 
the structural MRI literature in autism appears to hold few robust and consistently 
replicated findings. This impression may however reflect the fact that most studies of 
autism are small and underpowered.  Meta-analytic techniques allow the combination of 
small studies together, effectively increasing power and hence the reliability of the result.  
The use of these techniques, in combination with qualitative review, may be of use in 
determining the neuroanatomy of autism spectrum disorders.   
 
What follows is a systematic review of MRI studies of the brain in autism spectrum 
disorders with the methodology of meta-analysis applied to those brain regions for which 
sufficient numbers of publications were available.  An analysis of the confounding effects 









Medline, EMBASE and PsychINFO were searched for all English language studies 
published between January 1984 and March 2006 that reported structural MRI data in 
people with autism and unaffected controls.  Search terms included ‘autism’, ‘Asperger 
syndrome’, ‘pervasive developmental disorder’ and related terms combined using the 
AND operator with ‘magnetic resonance imaging.’  Both free-text and expanded medical 
subject headings were used.  Subject headings were adapted to the specific subject 
headings of the biomedical databases used.  The search strategy was supplemented by 
including a cited reference search and inspecting the reference lists of included articles.   
 
Criteria for inclusion 
All abstracts were independently assessed for inclusion by two people (including the 
author), and articles in full text were retrieved where appropriate.  Full text articles were 
then inspected independently by the same individuals, according to study inclusion 
criteria.  Any disagreements at either stage were resolved by discussion.   
 
Primary research studies were considered for inclusion if they were published as a peer-
reviewed article in English and compared a sample of autistic subjects with a group of 
healthy controls.  These comprised studies where subjects were described as meeting 
recognised diagnostic criteria for autism or other pervasive developmental disorders, or 
were reported as having received such a diagnosis in the past.  For the meta-analysis only 
43 
 
studies reporting structural MRI data where means and standard deviations were 
available (or could be extracted) for each group were included.  If a study combined 
autism and other pervasive developmental disorders together it was not included in the 
meta-analysis.   
 
Data abstraction 
Structural data was extracted from all included studies and recorded onto a spreadsheet 
along with a description of the anatomical feature, the type and unit of measurement (area 
or volume) and characteristics of the subject and control groups which possibly 
confounded any observed difference (including age, gender ratio and IQ).  
 
The majority of included studies provided full-scale IQ results from the Wechsler Adult 
Intelligence Scale (WAIS) or Wechsler Intelligence Scale for Children (WISC) as 
appropriate to the age of the subjects.  When verbal and performance IQ results were 
provided separately these were processed into full-scale IQ results according to standard 
protocols (WAIS manual).  
 
Data were utilised in the meta-analysis when volume or area results were available for a 
region of interest from three or more studies.  Where both volume and area data were 
available, only volumes were considered.  Area and volume data were never combined in 
the same analysis.  Additionally, where a study reported raw and adjusted values, the 
unadjusted values were utilised.  When there was evidence of repeat publication, only the 
study with the most data for each specific region of interest was chosen.  When a study 
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gave means by age and IQ stratified subgroups these were combined to give a pooled 
mean and standard deviation.  However, for the purposes of the meta-regression the 
values for each subgroup were also recorded separately.   
 
Data synthesis 
Statistical analyses were conducted using STATA SE version 8 (STATA Corp, College 
Station, TX).  Hedge’s unbiased estimator of standardised effect size,103 and its variance, 
was calculated from each study using the pooled means and standard deviations such that 
each study contributed only one data point per region of interest to the meta-analysis.  
Standardised effects sizes were then combined using random-effects meta-analysis using 
techniques based on the method of maximum likelihood.104  A random-effects approach 
was chosen over the more conventional fixed-effects analysis due to the likelihood that 
results may truly vary between studies, for example due to differences in population age 
and IQ, as opposed to differing through chance alone.  A random-effetcs analysis is 
therefore more conservative.  Publication bias was assessed using Egger’s test.  The size 
of between-study heterogeneity was estimated using the I2 statistic (a measure of the 
proportion of variance in summary effect size due to heterogeneity) and its statistical 
significance calculated using Cohen’s Q.105  Where I2 exceeded 50% and for the total 
brain volume, the modifying effects of age, gender and IQ were investigated using meta-
regression.  Only studies for which age, gender and IQ data were available were included 
in the meta-regression and when studies provided data in age or IQ defined subgroups 
these were considered as separate data points in the appropriate analysis.  A regression 
model was fitted to the data with the mean age and IQ of autistic subjects fitted as fixed 
45 
 
effects.103  Study was modelled as a random effect and the model estimated using residual 
maximum likelihood (REML).  Where significant relationships were found their nature 
was investigated graphically by fitting the ordinary least squares line to the data points.  
The meta-regression was also repeated using the pooled mean values to ensure that the 
results were not related to one study contributing a disproportionate number of data 
points to the analysis.  
 
Qualitative Reviews 
Qualitative reviews were carried out for those studies which included subjects with 
pervasive developmental disorders other than autism, voxel-based morphometry studies 

















42 publications were included in the meta-analysis and provided information regarding 
18 regions of interest from almost 800 individuals with autism and a similar number of 
controls.  The exact number could not be calculated as overlapping groups of subjects 
provided data for different brain regions in different publications.  Table 3.1 lists the 
demographic and diagnostic information for each study report included in the meta-
analysis.  Those with overlapping populations are indicated and results by age group are 
recorded in italics under the pooled means and standard deviations of the parent study.   
Study flow and reasons for exclusion from the meta-analysis 
Figure 3.1 
The literature search of the three databases yielded 656 articles and a further 2 articles 
were identified through the supplementary search strategies.  Figure 3.1 summarises the 
study flow and reasons for exclusion.   
 
3.3 Results 
42 articles included in the meta-
analysis 
77 potentially appropriate articles 
to be included in the meta-analysis 
114 articles retrieved for full text 
evaluation 
658 potentially relevant articles 
identified and screened for retrieval 
Exclusions: repeat publication (14), 
not enough studies examined region 
(15), raw data not reported (6) 
Exclusions: not structural (3), not 
region of interest (8), not 
quantitative (15), not autism (6), 
not normal controls (5) 
 
 
  Autistic Subjects Control Subjects  
Study (year) Diagnostic instruments N (M:F) 
Mean / 
median age Mean IQ N 
Mean / 

























































Carper (2000)107 DSM-IV, CARS, ADI, ADOS 42 (42:0) 5·4 79·5 29 (29:0) 6 114 VI-VII 


























Cieseilski (1997)109 DSM-III-R 9 (5:4) 16·8 - 10 (7:3) 16·6 - I-V, VI-VII, pons 
Courchesne (1994)110 DSM-III 50 (41:9) - - 53 (43:10) 18·8 - I-V, VI-VII 
Egaas (1995)111 DSM-III-R, CARS, ADI, ADOS 51 (45:6) 15·5 - 51 (45:6) 15·5 - cc 
Elia (2000)112 DSM-IV, CARS 22 (22:0) 10·9 - 11 (11:0) 10·9 - cc, mb, pons, vermis, VI-VII 
†Gaffney (1987)113 DSM-III 13 (10:3) 11·3 84·9 35 (21:14) 12 - cc 
†Gaffney (1988)114 DSM-III 13 (10:3) 11·3 84·9 35 (21:14) 12 - med, mb, pons 
‡Garber (1989)115 DSM-III 15 (11:4) 11·6 - 15 (11:4) - - 4V 
‡Garber (1992)116 DSM-III 12 (9:3) 27·2 - 12 (8:4) 26·4 - 4V, pons, vermis, I-V, VI-VII 
**Hardan (2000)117 ADI, ADOS 22 (22:0) 22·4 100·4 22 (22:0) 22·4 100·5 Cc 
**Hardan (2001)118 ADI, ADOS 16 (16:0) 22·2 102·8 19 (19:0) 22·2 101·2 icv, cbr 
**Hardan (2001)88 ADI, ADOS 22 (22:0) 22·4 100·4 22 (22:0) 22·4 100·5 
cbl, vermis, I-V, VI-
VII, VIII-X, 4V, med, 
mb, pons 









































































vermis, I-V, VI-VII, 
VIII-X, 4V, med, mb, 
pons 
††Hazlett (2006)121 DSM-III-R, ADI 23 (23:0) 19·1 89·9 15 (15:0) 21·6 102·3 Cbr 
Haznedar (2000)98 DSM-IV, ADI 10 (-:-) - - 17 (15:2) 28·8 - tbv, amy, hc 
Herbert (2003)122 DSM-III-R, WADIC 17 (17:0) - >80 15 (15:0) - >80 tbv, caudate, cbl 
Holttum (1992)123 DSM-III-R, ADI, ADOS 18 (18:0) 20·2 94·5 18 (18:0) 20·2 95·2 I-V, VI-VII, VIII-X 
Howard (2000)99 DSM-IV 10 (10:0) 23·8 99 10 (10:0) 24·2 102 icv, cbr, amy, hc 
Hsu (1991)124 - 34 (27:7) 18·9 82·6 44 (40:4) 19·8 113 mb, pons 
Kates (2004)125 ABC, ADI-R, ADOS 8 (7:1) 7·6 69·6 16 (14:2) 8·3 123·6 Tbv 
Kaufmann (2003)90 DSM-IV, ADI, ADOS 10 (10:0) 6·9 66·1 21 (21:0) 8·3 120·8 I-V, VI-VII, VIII-X 
Kleiman (1992)89 DSM-III-R 10 (8:2) 6·6 - 17 (-:-) - - pons, I-V, VI-VII 
Levitt (1999)126 DSM-IV, ADI 8 (-:-) 12·5 83·3 21 (-:-) 12 114·9 VIII-X 
Lotspeich (2004)127 ADI, ADOS 31 (31:0) 11·9 - 21 (21:0) 12·5 - cbr 
McAlonan (2005)128 ADI-R 17 (16:1) 12 101 17 (16:1) 11 114 tbv 
Pierce (2001)97 DSM-IV, CARS, ADI, ADOS 6 (6:0) 29·5 83·7 8 (8:0) 28·3 - amy 
Piven (1992)129 DSM-III-R, ADI 15 (15:0) 27·7 92·5 30 (30:0) 29·6 115 pons, I-V, VI-VII 





Demographic characteristics of included study populations 
–: no data available, DSM: Diagnostic and Statistical Manual, III: third edition, IIIR: third edition revised, IV: fourth edition, ADI: 
Autism Diagnostic Inventory, ADOS: Autism Diagnostic Observational Schedule, CARS: Childhood Autism Rating Scale, WADIC: 
Wing Autistic Disorder Interview, CLAC: Checklist for the Autistic Child,  icv: intracranial volume, tbv: total brain volume, cbr: 
cerebral hemispheres, cbl: cerebellum, amy: amygdala, hc: hippocampus, cc: corpus callosum, med: medulla, mb: midbrain, 4V: 4th 
ventricle 
*, **, †, ††, ‡: studies with overlapping subject groups. 
Age and IQ stratified results, when given, are entered under the pooled means for each study in italics
††Piven (1996)130 DSM-III-R, ADI 35 (26:9) 18 91 36 (20:16) 20·2 102·1 icv 
††Piven (1998)131 DSM-III-R, ADI 35 (26:9) 18 91 36 (20:16) 20·2 102·1 hc 


























cbr, amy, hc 
 
††Sears (1999)133 DSM-III-R, ADI 35 (26:9) 18 91 36 (20:16) 20·2 102·1 caudate 
Sparks (2002)92 DSM-IV, ADI, ADOS 29 (26:3) 3·9 - 26 (18:8) 4 - 
tbv, cbr, cbl, hc, amy, 
caudate 
Townsend (1999)134 DSM-III-R, CARS, ADI, ADOS 15 (-:-) 27 79 43 (-:-) 36·3 116 icv, tbv 
Tsatsanis (2003)135 DSM-IV, ADI, ADOS 12 (12:0) 21 106·4 12 (12:0) 18·1 108·8 tbv 
Vidal (2006)136 DSM-IV, ADI, ADOS 24 (24:0) 10 95·9 26 (26:0) 104·8 11 tbv, cc 
 
Meta-analysis and meta-regression 
Standardised effect sizes (denoted by ES in the text), and their 95% confidence intervals, 
for the 18 regions of interest are presented in Table 3.2 along with estimates of 
heterogeneity.  Statistically significant effects were obtained for 9 regions of interest. In 
order of effect size, areas of the midbrain (ES -0·77), vermal lobules VIII-X (ES -0·43), 
the corpus callosum (ES -0·28) and vermal lobules VI-VII (ES -0·27) were significantly 
smaller in autistic subjects compared to controls.  In contrast, cerebellar (ES 0·72), 
cerebral hemisphere (ES 0·62) intracranial (ICV, ES 0·51), caudate (ES 0·41) and total 
brain (TBV, ES 0·33) volumes were significantly increased in autistic subjects compared 
to controls.  Substantial overlaps in the confidence intervals indicated that there were no 
significant differences in the magnitude of the effect sizes between regions.   
 
Statistically significant heterogeneity was seen for 9 of the 18 regions examined 
including several for which no differences between autistic subjects and controls were 
found.  Significant relationships were found between the effect size for the cerebellar 
vermal lobules VI-VII and the mean age (p=0·02) and IQ (p<0·01) of the autistic 
subjects.  Graphical representation of these relationships indicated that as subject age and 
IQ increase the observed reductions in vermal lobules VI-VII become less apparent 
(Figure 3.2 & 3.3).  In addition significant relationships were found between age and 
effect size for the left and right amygdalae (p=0·04 and p=0·01 respectively).  The graphs 
for both demonstrate that as age increases amygdala volume in autistic subjects decreases 
relative to controls (Figure 3.4).  There were no significant relationships with age, gender 
or IQ for any of the other regions including for age and total brain volume (p=0·22) 
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(Figure 3.6).  In line with a previous meta-analysis 137 a 2nd order regression line was 
fitted to the age-total brain volume data which was also non-significant.  There were no 














14 (19) 0·33 (0·14, 0·51)† 31·8 19·07, 0·12 0·51 TBV 
4 0·51 (0·20, 0·81)† 0·0 1·23, 0·75 0·39 ICV
7 (8) 0·62 (0·39, 0·86)† 0·0 5·36, 0·50 0·79 Cerebrum 
4 0·72 (0·40, 1·03)† 0·0 0·88, 0·83 0·25 Cerebellum 
3 0·41 (0·12, 0·71)† 0·0 1·58, 0·46 0·62 Caudate 
6 (7) 0·15 (-0·46, 0·76) 75·8 20·68, <0·01 0·31 Amygdala L
6 (7) 0·28 (-0·32, 0·88) 74·9 19·94, <0·01 0·16 Amygdala R
6 0·41 (-0·11, 0·93) 74·5 19·64, <0·01 0·78 Hippocampus L
6 0·29 (-0·27, 0·86) 78·8 23·56, <0·01 0·72 Hippocampus R
4V 3 0·22 (-0·28, 0·72) 28·4 2·79, 0·25 0·70 
Areas 
9 (17) 0·10 (-0·28, 0·49) 71·5 42·97, <0·01 0·46 I to V
12 (20) -0·27 (-0·51, -0·03)† 52·0 32·53, 0·03 0·38 VI to VII
5 (13) -0·43 (-0·80, -0·06)† 49·5 18·78, 0·09 0·76 VIII to X
4 (12) -0·22 (-0·51, 0·07) 20·7 13·83, 0·24 <0·01 Total vermis 
3 (11) -0·99 (-2·17, 0·18) 92·8 34·73, <0·01 0·62 Medulla
5 (13) -0·77 (-1·52, -0·02)† 90·2 47·38, <0·01 0·52 Midbrain
5 -0·28 (-0·52, -0·03)† 0·0 0·43, 0·98 0·21 Corpus callosum
Table 3.2 
Pons 9 (17) -0·53 (-1·19, 0·13) 90·6 97·31, <0·01 0·42 
Effect sizes and estimates of heterogeneity and publication bias for the 18 regions of interest 
‡ Numbers in brackets represent the total number of data points used in the age meta-regression 































Graph of standardised mean difference (SMD) versus mean age of the autistic groups for 
vermal lobules VI-VII 





























Graph of standardised mean difference (SMD) versus mean IQ of the autistic groups for 
vermal lobules VI-VII 
Only studies reporting IQ results are included and when studies providing data by IQ 


















































Graph of standardised mean difference (SMD) versus mean age of autistic groups for 
olume total brain v































Evidence of publication bias was found only for the total vermal area (Egger test p<0·01).  
raphical investigation of this result suggests that larger studies found smaller vermal 
areas in subjects with autism compared to controls whereas smaller studies found the 
opposite result.  However, the small number of studies of this region (n=4) makes 
interpretation difficult.   
 
Brain regions with insufficient replication to be included in meta-analysis 
Data regarding regions of interest which were not examined by sufficient numbers of 
studies to be included in the meta-analysis are summarised in Tables 3.3-3.8.  These 
tables include studies which were excluded from the meta-analysis and some which were 
included as they provided data on other regions.  Studies which reported area 
measurements of regions which were included in the meta-analysis as volumes are not 
discussed.  
 
Enlargements in either grey or white matter are reported for the frontal, temporal and 
parietal lobes in six out of six, six out of seven and four out of six studies respectively.  
However, only two out of six studies report occipital enlargements suggesting that this 
lobe is relatively spared.  It is less clear whether grey and white matter compartments are 
affected equally as the studies show little consistency regarding this.  Unfortunately these 
issues could not be considered in the meta-analysis as the volumes were variously 
reported for the whole lobes, for grey and white matter in each lobe, for each side 
separately or as covaried means, meaning they could not be combined.  There are 







olding seen in autism.  Hardan et al found an 
crease in the left prefrontal gyrification index (i.e. greater cortical folding) in children 
our studies used voxel-based morphometry (VBM) and these are summarised in Table 
ese used single slice 2-dimensional 2D VBM and examined only the 
fied 
affected differently.  In particular, differences in asymmetry in brain regions assoc
with language production, such as the planum temporale and Broca’s area, have been 
reported although the direction of asymmetry differs between studies.132,138,139  Structura
changes in the parahippocampal gyrus140 and the cingulate gyrus141 have also been 
reported although only in one study each.   
 
Two studies address the pattern of cortical f
in
and adolescents with autism relative to normal controls.  The same relationship was not 
seen in adults.  They also report a negative relationship between the gyrification index 
and age in controls which was not seen in subjects with autism.120  Taking a different 
approach Levitt et al created maps of major cerebral sulci in autism and examined 
differences in their location in Talairach space.  They reported anterior and superior 




3.9.  One of th
corpus callosum finding reductions in both anterior and posterior regions.143  One study 
found no differences but considered only 9 individuals,144 while the other two identi




  Autistic Subjects Control Subjects   















52 (52:0) 6.2 67 15 (15:0) 3.6 - - Increased cerebral GM and WM. 
**Boucher 
(2005)140 DSM-IV 10 (10:0) 23.8 99 10 (10:0) 24.2 102 - 
Reduction in parahippocampal gyrus. No 
































Increased frontal GM and WM, temporal GM 
and parietal WM in 2-4 year olds.  No difference 
























Increased left prefrontal gyrification index in 
subjects under 18 years old. 

















Vs low IQ controls – increased GM and WM in 
all 4 lobes. 
Vs“normal” IQ controls – increased WM in 
temporal lobes, and right parieto-occipital lobes, 




ADI 23 (23:0) 19.1 89.9 15 (15:0) 21.6 102.3 age, IQ 
Increased left frontal and temporal GM. 








WADIC 13 (13:0) 9.0 >80 14 (14:0) - - - 
Increased “superficial” frontal, temporal, 
parietal and occipital WM. 
No difference in “deep” white matter. 
**Howard 




R, ADOS 8 (7:1) 7.6 69.6 16 (14:2) 8.3 123.6 tbv 
Reduced frontal, temporal and occipital WM. 




ADI, ADOS 21 (-:-) 10.7 98 20 (-:-) 11.3 114 - 





repl tio clu in th meta-analysis (excludin
St cort  s ch at rod on ism 
 
Lotspeich ADI-R, 31 ( 21 (2 age, site Increase in rebral GM. No M. 
able 3.3 
Studies of cortical regions with insuffici
Abbreviations as in Table 3.1 
ent ica n to be in ded e g regions involved in speech) 
Table 3.4   
udies of ical regions involved in pee gener ion and p ucti  in aut
(2004)127  ADOS-G 31:0) 11.9 - 1:0) 12.5 - 
 ce






6 (6:0) 29.5 83.7 8 (8:0) 28.3 - - No difference in fusiform gyrus, inferior temporal gyrus or middle temporal gyrus 
(1996)130 
D , 35 (26:9) 18 91 36 (20:16) 20.2 102.1 - 
Incr  lobe 
volumes. Piven SM-III-RADI 
eased frontal, temporal and parietal
No difference in occipital lobes. 



















22 (22:0) 9.4 86.8 11 (11:0) 10.4 114.5 - 
Reversal s area for of asymmetry in Broca'
autistic subjects with language impairment. 




WADIC 16 (16:0) 9.0 >80 15 (15:0) 8.3 - - 
R opercularis eversal of asymmetry in pars 
(associated with Broca’s area). 




A  DI, ADOS 15 (13:2) 29.9 92.5 15 (13;2) 30.4 119.6 - 
Reduction in left planum temporale leading to 
loss of asymmetry in autism. 
No di emporale or fference in right planum t
Heschl’s gyrus 
Rojas 




rale. DSM-IV, Loss of asymmetry of planum tempo




on and limbic structures in autism 
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Studies of the basal ganglia, diencephal




















(2005)140 DSM-IV 10 (10:0) 23.8 99 10 (10:0) 24.2 102 - 
Reduction in parahippocampal gyrus. 
 
Hardan 




ADI 7 (5:2) 24.3 - 7 (5:2) 26.4 - tbv 
Reduced right anterior cingulate area 24’. 
Increased right anterior cingulate area 25. 
(2003)122 WADIC 0) 9 >80 15 (15:0) - - age, wbv, site 
on-
significant when covary for brain volume). 
Increased diencephalon. 
No difference in amygdala-hippocampal 
complex. 
Herbert DSM-III-R, 17 (17:




ADI, ADOS 12 (12:0) 21 106.4 12 (12:0) 18.1 108.8 - 
No difference in thalamus vo mes in whole lu
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ons as in Table 3.1 
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tudies of the ventricular system in autism 
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51 (45:6) 15.5 - 51 (45:6) 15.5 - - Reduction in posterior regions of corpus callosum. 
Hardan 




ADI 35 (26:9) 18 91 36 (20:16) 20.2 102.1 
 
ge , IQ, tbv nder Reduction in body and splenium. 
Manes DSM-IV, 27 (22:5) 14.3 - 17 (11:6) 11.8 - midsagittal rea (1999)152 CARS, ADI intracranial a
Reduction in genu, rostral body, anterior 




ADI, ADOS 24 (24:0) 10.0 95.9 26 (26:0) 11.0 104.8 age Reduction in anterior third 
  Autistic Subjects Control Subjects   








IQ Covariates Main Findings 
Hardan 
(2001)118 ADI, ADOS 16 (16:0) 22.2 102.8 19 (19:0) 22.2 101.2 - 
No difference in size of lateral ventricles. 
Increased third ventricle. 
Howard 




ADI 22 (22:0) 18.4 90.8 20 (20:0) 21.6 103.4 Increased lateral ventricles height, IQ 
 












IQ Covariates Main Findings 
Table 3.8 
















85 8 (7:1) CARS, ADI-
R, ADOS 










2.5 86.3 No di o fference in GM or WM compared t2.7 
2.4 
58.5 age, gender either control group 108.1 






Studies which used VBM to examine neuroanatomy in autism 
SVC – small volume correction 
 












IQ Notes Main Findings instrument




ADI-R 21 (16:5) 9.3 <70 12 (7:5) 10.8 >70 
VBM, temporal 
lobe SVC 
GM reductio poral sulcus ns in superior tem
bilaterally. 





ADI-R 16 (16:0) 16.1 >70 12 (12:0) 17.1 >70 
2D VBM of 
c um orpus callos







9 (9:0) 14.0 >70 13 (13:0) 13.6 >70 VBM No differences 
6:1) 12 101 17 (16:1) 11 114 VBM 
GM reductions in bilateral orbital and 
medial frontal gyri, left middle frontal 
gyrus, right inferior frontal gyrus, right 
middle frontal gyrus, left middle and 
superior temporal gyri, right 
parahippocampal and fusiform gyri, 
bilateral precuneus and cingulate gyrus, 
bilateral caudate nucleus and brainstem 









Studies which exam arised in Table 
3.10.  Of these there were 5 which exam aining 
7 combined individuals with au
only Asperger disorder 3 contained regi  one for the whole 
cerebrum;127 one for the cerebral lob 154 and one gave 2-
dimensional length and diameter measurements for the corpus callosum and 
mesencephalon. any significant differences between 
individuals with Asperger syndrome and unim red controls while the last found only a 
reduction in the anterior-posterior diameter of the mesencephalon.  The VBM studies of 
Asperger syndrom repo re atter reductions in the frontal lobe and both 
enlargem poral structures.144,154,156  The remaining studies in 
Table 0 report data for groups containing some individuals with autism and some with 
other PDDs.  A variety of findings are reported including widespread increases in grey 








ents and reductions in tem
155   Neither of the first two found 
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28.8 - 15 (12:3) 25.3 - - 
VBM study 
In  i  left am da r cerebellar creased GM n yg la, bilateral anterio
lo er r is  m e t ra us and right be, c ebella verm , left iddl empo l gyr
inf rior te poral gyrus e m  
Decr sed  pa cingu ate suea  GM in right ra l lc ft inferior us, le
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13.5 - 13 (13:0) 13.6 - - 
VBM study 
Decreased G ci te s nferior temporal  M in ngula  gyru and i
gyru bilate ally, r ht en hina cortes r ig tor l x, right fusiform 
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12.7 108 21 (21:0) 12.5 114 age, s e it N  signi cant fferen e in c rebralo fi di c e  GM or WM 
McAlonan 




32 96 14 (14:0) 33 114 Age,  IQ
No d feren  in to l bra , cere ral loif ce ta in b bes, cerebellum, 
b sal ga glia o later venta n r al ricles. 
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f interest and voxe sed studies concerning PDD 
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nuclear and subgyral regions. 
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ri
bule, insula a
Reduced WM in isthmus and splenium of callosum 
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M
M  , however 
m ed o a ts with IQs of over 70.  Given that around 70% 
o s w ism a g disab  th s c  in females 
(although less commonly than in males) the a  lite  i t resentative 
of the general clinical population.  Most of the study groups were well matched for age, 
gender and IQ, the exceptions being some studies which examined people with autism 
and low IQ.  In these the control groups were often of higher IQ than the cases.  The lack 
of IQ group risks introducing error as the gro s differ on both IQ
and clini tatus ther tha inical status ne.   
 
W th t m y of reviewed abstra re written in English there were
non-English studies excluded which, judging from the abstracts, may have met inclusion 
cr ia a t is p ble tha s may affect the results.  Howev he effect of 
be minimised by the inclusion of several studies which were published in Englis
were carried out in non-native English speaking countries such as Norway and J
tly papers w cluded from t ta-analysis 
did not present raw data and others were excluded as they combined autistic indi
w o fe om rvasive mental disorders.  In addition, as can be 
seen from Tables 3.3 -3.8, a considerable amount of data was excluded regarding regions 
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worthy of some consideration further replication is required before firm conclusions can 
e made.   
 
   








Main findings and clinical implications 
Consistent evidence was found for an increase of the total brain volume, the cerebral 
hemispheres and the cerebellum in autism.  In addition, an increase in the volume of the 
caudate nucleus was seen whereas the corpus callosum was reduced in size.  Reductions 
in the size of the midbrain and the cerebellar vermal lobules VI-VII and VIII-X were also
found although with significant heterogeneity.  For vermal lobules VI-VII this 
heterogeneity was related to the age and IQ of the study population.  While no difference 
in size was found for the amygdala a significant effect of age on the data was apparent.
 
T
studies of autistic individuals which have reported megalencephaly, cortical thickening
and an increase in cerebral neuronal density.165  Increased numbers of smaller and less 
dense cortical minicolumns (vertical chains of cells extending through the cortical layers 
thought to be functional sub-units of cortex) have also been reported at post-mortem.16
A larger less well organised cerebral cortex has been hypothesised to lead to inefficient
connectivity and less integration of dispersed brain regions, a view supported by a variet
of functional neuroimaging studies.167  The reduction in the cross-sectional area of the 
corpus callosum indicates that inter-hemispheric connectivity is also likely to be less 
efficient in autism and there is evidence from neuropsychological tests that  this is indeed 
the case.168  Furthermore the enlargement of the cerebellum is likely to further affect 
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co-ordination of brain activity.  Previously regarded as being solely involved in motor 
activities, it is now known that the cerebellum also connects to cortical regions involved 
 emotional and cognitive functions and it is thought to play a similar role in these 
ction.169,170  A lack of integration and regulation 
e 
m 





domains as in the regulation of motor fun
of distributed brain functions could lead to deficits in complex processes which requir
the recruitment of a variety of brain regions, such as language and social behaviour.167  
 
An increase was also found in caudate volume, without evidence of heterogeneity.  This 
finding was also recently reported in a study of individuals with autistic spectru
disorders in which the size of the caudate was found to correlate with the degree of 
restricted, repetitive behaviours.157  Previous findings of enlarged caudate volume and 
a
disorder lend further, albeit indirect, support to this result.171  It is therefore likely that
caudate enlargement in autism is linked to an intrinsic abnormality of neuronal circuitry 
although it is possible that the use of antipsychotic medications, which have been 
associated with caudate enlargement,172 may be confounding the findings.  Unfortunately,
there was not enough information in the original reports to discern whether or not those 
with autism were receiving psychotropic medications, let alone to examine any potential
dose relationship.   
 
Effect of confounding variables 
The midbrain and lobules VIII-X of the vermis were found to be reduced in size but with 
significant heterogeneity which was not explained by age or IQ.  These findings should 
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therefore be interpreted with great caution.  Lobules VI-VII of the vermis were also 
reduced in size and the heterogeneity of this finding was at least partly accounted for by 
differences in the age and IQ of the study population.  As can be seen in Table 3.1 th
case and control groups for this region were generally well matched for age.  The 
significant finding for age therefore represents a change in the difference in vermal size 
between the groups as they grow older, i.e. there may be a different growth trajectory fo
e 
r 






nificant effect on the results for the amygdala with 
th
of size with increasing age (Figure 3.2).  The largest single study of this region, which 
included 98 autistic individuals, found a similar relationship with age to that which
identified in the meta-regression.87  While this study contributed 9 data points to the
meta-regression the result remained significant even when these were pooled to give on
mean value showing the findings are not driven solely by this study.  With respect 
the lower the IQ of the autistic groups the less well matched they were to the control 
groups which tended to be of average IQ.  Therefore the significant finding for IQ 
indicates that as the IQ differences between the groups lessen so do the volumetric
differences (Figure 3.3).  Taken together these findings indicate that younger autistic 
individuals show real reductions in the size of vermal lobules VI-VII whereas those 
identified in older individuals may be an artefact of IQ differences between case and 
control groups.   
 
Age was also found to have a sig
younger autistic individuals showing enlargements which are not present in older groups.  
Functional imaging studies indicate that the amygdala is involved in social cognition, in 
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particular empathy and “theory of mind” (the ability to attribute mental states to 
others).173  It has been shown that lesions in childhood are especially likely to lead to 
theory of mind impairments.174  Deficits in social cognition are characteristic of autism
and the early structural abnormality of the amygdala reported is likely to play a key
in the development of such impairments.   
 
No statistically significant relationship was found between age and effect size for total 
brain volume, a result which appears to contrast with that of a previous meta-analysis o









ation from Qualitatively Reviewed Data 
 general caution is advised in interpreting the results for regions which were not 
ey 
137  They found tha
brain volume enlargements are apparent in young children in the first 4 years of life b
normalise following this period.  The difference between the two meta-analyses is the 
inclusion of head circumference studies in infants under 2 years old as a proxy for brain 
volume in the Redcay and Courchesne report.  It is possible that the current study did 
find an age-brain volume relationship due to a lack of MRI studies in these very yo
autistic individuals.  Certainly the two studies in the current meta-analysis pertainin
subjects around 4 years old show markedly greater effect sizes when compared with 




included in the meta-analysis and until there is replication of many of the findings th
should be regarded as preliminary.  In general frontal and temporal regions appear to be 
the most consistently identified as abnormal by ROI, VBM and studies of cortical 
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folding.  These regions are particularly involved in executive function, social beh
and language all of which are disturbed in autism.  The abnormal asymmetry in langua
regions reported by a number of studies suggests that a disturbance of lateralisation may
be relevant in autism.  Further evidence for this is provided by findings of increased rates





ctural changes reported for the 
arahippocampal gyrus and the cingulate gyrus along with post-mortem reports of 
e 
ces 
e to combine them for study.127,144  It is 
erefore possible that the findings of such studies will depend upon the relative 




175  The stru
p
increased cell packing density in the cingulate cortex176 suggest that abnormalities of th
limbic system beyond those found in the amygdala may also be important in the 
pathogenesis of autism.   
 
Studies concerning PDD 
It is difficult to interpret the findings of those studies which examined PDD due to the 
tendency of researchers to combine subjects with autism and those with other PDDs 
together.  The status of these PDDs in relation to autism is unclear and it is not known 
whether they share similar neuroanatomical features.  Those studies which have directly 
compared Asperger syndrome with autism have found some neuroanatomical differen
between the two suggesting that it may not be wis
th
proportions of subjects with autism to those with other PDD
studies by Palmen et al concern mainly individuals with autism and are thus likely 
primarily reflect the neuroanatomy of autism as opposed to that of other PDDs.158,159  Of
the studies which examined Asperger syndrome alone the ROI studies tended to find no 
volumetric differences whereas the VBM studies detected tissue density difference
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the frontal and temporal lobes (although not necessarily in the same direction).  This 
suggests that if the brain is different in Asperger disorder this is more subtle than is seen 
in autism although more research is required to confirm this.   
 
Concluding Remarks 
On the basis of the existing literature, we can conclude that autism is associated wit
enlargements of the cerebral hemispheres, the cerebellum and the caudate nucleus; with 
reductions in the size of the corpus callosum and possibly the midbrain and vermal 
lobules VI-VII and VIII-X
h 
.  In addition the vermal lobules VI-VII and the amygdala may 
ow unusual growth trajectories.  Within the cerebrum the frontal and temporal lobes 




appear to be most affected
features of the disorder may result from a combination of a global lack of integration an
regulation of dispersed brain regions and more specific abnormalities in particular 











Introduction to Experimental Section 
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4.1  The Edinburgh Study of Comorbidity  
 
The Edinburgh Study of Comorbidity (ESC) is a large, ongoing prospective study which 
was designed to identify and investigate a group of adolescents at high risk of developing 
schizophrenia by virtue of being cognitively impaired.  There is a well established 
association between schizophrenia and cognitive impairment.177  Reductions in cognitive 
functioning compared to normal controls have been reported both prior to and after the 
onset of illness.178-180  Despite this the majority of individuals with schizophrenia have 
IQs in the unimpaired range.  However, among the learning disabled population (people 
with an IQ of less than 70) there is an excess of schizophrenia with prevalence rates being 
three times greater than those in non-learning disable people.181  Research which has 
examined adults who are comorbid for learning disability and schizophrenia has shown 
that such individu  with 
schizophrenia rather than non-schizophrenic learning disabled adults in terms of brain 
structure.  This suggests that the cause of the learning disability in the comorbid group is 
in fact severe schizophrenia.  In turn this raises the possibility that within a population of 
adolescents with learning disability there are some whose learning disability is the result 
of a psychotic illness which is yet to become manifest.182  This premise is key to the 
design of the ESC.   
 
As important to the design of the ESC are the results from the Edinburgh High Risk 
Study (EHRS) which show that within a population of individuals who are at high risk of 
developing schizophrenia by virtue of genetic reasons, it is possible to predict those who 
als more closely resemble non-learning disabled adults
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will go on to develop schizophrenia using easily administered rating scales of behaviour 






Interview for Schizotypy (SIS)).184  These findings allow the identification and detailed 
investigation of subjects who have the highest risk of developing schizophrenia by virtue 
of being not only cognitively impaired but also because they display the behavioura
symptoms and schizotypal features which predicted the development of schizophrenia in 
the EHRS.  Clearly the ESC rests on the assumption that the two high risk populations 
(the genetic high risk population in the EHRS, and the cognitively impaired high risk 
population in the ESC) will prove to show similarities in terms of the pattern of illness 
development.     
 
Due to the overlap of schizotypal and autistic features, it was recognised that a number o
subjects with autistic features would also be recruited into the ESC.  Thus a me
autistic features (the Social Communication Questionnaire (SCQ))185 was also included











4.2  The Current Study 
 
What follows is an examination of the brain structure associated with schizotypal and 
autistic features in the baseline sample acquired for the Edinburgh Study of Comorbidity 
(ESC).  This unique sample allows a number of important issues to be addressed.  Firs
as discussed in Chapter 3 the existing research on PDD focuses mainly on high-
functioning individuals despite the fact that this is not representative of the populations 
seen clinically who are primarily of low IQ.  In addition those that have studied low IQ




ility that any results identified relate to IQ differences rather than 
utistic features.  In the following study autistic features are studied across a wide range 
, therefore the clinical and neuroanatomical features of this 
roup are considered here.  Finally the ESC allows a comparison between schizotypal 
nd autistic features with respect to neuroanatomical measures and an examination of 
dividuals who are comorbid for both conditions. 
he emphasis is on the current status of participants and not their future likelihood of 
eveloping schizophrenia.  In this context the CBCL is of limited usefulness due to its 
ck of specificity with respect to diagnosis therefore it is not considered further.  
owever the SIS allows the identification of subjects with significant degrees of 
a
of IQ with a developmentally appropriate control group in addition to an unimpaired 
control group.  No previous research has studied the neuroanatomy of schizotypal 
features in individuals with learning disability, despite the high prevalence of 











schizotypy, while the SCQ scores can be used to identify those with autistic features.  




.  All 
suggest 
 to 
addition after birth, the midsagittal 
rea of the corpus callosum continues to grow, particularly in the first few years of life.186  
n 
T
corpus callosum and the degree of prefrontal cortical folding.  Each of these measures 
been seen in the relevant literature reviews to be abnormal in ASD and/or schizotypy.  
Before continuing it is useful to consider each measurement in detail, with the exception 
of the whole brain volume. 
 
The Corpus Callosum 
The corpus callosum is the largest white matter tract in the human brain and serves 
interhemispheric communication between homologous cortical areas.  Development 
begins early in gestation and proceeds in an anterior-posterior direction.  An exception to
this is the rostrum which develops last and folds under the anterior callosum or genu.186
In utero the growth of the corpus callosum is primarily due to the addition of axons
of the callosal axons are in place by the time of birth – there is no evidence to 
axonal addition postnatally.   Primate studies have shown that immediately following 
birth the corpus callosum has many more fibres than are present in the adult brain.  
Around 70% of these fibres are eliminated in the first 3 postnatal months at rates of up
50 fibres per second.187  Despite the lack of axonal 
a
Growth continues at a slower rate throughout childhood and adolescence particularly i
the posterior and middle corpus callosum with the anterior regions remaining largely 
unchanged.188  It is likely that the postnatal growth of the corpus callosum is primarily 




Axonal fibres in the corpus callosum are topographically organised such that the differen
sub-regions contain axons from different areas of the cortex (see figure 5.2).
t 
y 
ing fibres,190 changes in this area should provide information 
egarding the number of neurones from which the fibres originate.  Thus the corpus 






disproportionate amount of the human brain 
189  
Abnormalities in sub-regions may therefore reflect irregularities deriving from relativel
specific cortical areas.  Given that the midsagittal area of the corpus callosum correlates 
with the number of decussat
r
callosum provides a use
in the cerebral cortex.  However, as discussed above, postnatal growth of the callosu
primarily due to fibre myelination therefore disturbances to this process may also affe
the measured callosal size.  Examining the relationship between regional cortical grey 
matter and the relevant callosal sub-region may help to clarify whether callosal size 
differences relate to myelination or change the number of axons.   
 
The Prefrontal Lobe 
The prefrontal lobe is the most anterior part of the human brain and lies in front of th
motor and premotor areas of the frontal lobe.  It is defined by the presence of a prominent 
cell layer IV (granular layer) and is divided into three neuroanatomical regions – lateral
medial and orbital.  In typically developing humans the prefrontal lobe grey matter 
increases in size from birth until around the age of 12 when it begins to gradually 
decrease.  In contrast the white matter compartment continues to grow into late 
adolescence and early adulthood due to axonal myelination.191  Comparative studies hav
shown that the prefrontal lobe makes up a 
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relative to other mammals (29% as compared to 17% in chimpanzees, 12.5% in dogs and 
was not previously his custom), manifesting but little deference for his 
desires, at times pertinaciously obstinate, yet capricious and vacillating, 
than they are abandoned in turn for others appearing more feasible.”    
me of the classic signs 
f frontal lobe dysfunction.  Subsequent lesion studies and, more recently, functional 





3.5% in cats).192  This expansion of the prefrontal lobe is assumed to parallel the 
evolution of higher order cognitive functions.   
 
The study of prefrontal lobe function and dysfunction effectively began with the case 
description of Phineas Gage.  A railway worker who sustained a penetrating injury to the 
prefrontal region, Gage was described by his physician as 
 
“fitful, irreverent, indulging at times in the grossest profanity (which 
fellows, impatient of restraint or advice when it conflicts with his 
devising many plans of future operations, which are no sooner arranged 
193
 
Unable to plan his actions or limit his behaviour Gage displayed so
o
MRI studies have pro
prefrontal lobe.  Broadly speaking the lateral prefrontal region is involved in working 
memory and preparatory set the intact functioning of which are essential for effective 
planning and sequencing of thought and behaviour; the medial region is involved in drive
and motivation; and the orbital region in impulse control and response inhibition.  A
three regions are involved in aspects of attention.192  Subtle impairments in all thes
domains have been hypothesised to relate to the behavioural symptoms and cogn




The Gyrification Index 
The gyrification index is a widely used measure of the degree of cortical folding. 
Initially lissencephalic (smooth) the human brai
 
n begins to fold at about 20 weeks 
estation to form ridges or gyri which are separated by indentures or sulci.  The first sulci 
ndary sulci while those of 
condary sulci are called tertiary sulci.  These are less deep and more variable in their 
position s tertiary 
sulci co
 
oth genetic and environmental factors appear to be important in determining the 




to appear are called primary sulci and are remarkably consistent in their placement 
between individuals.  Examples of primary sulci include the Sylvan fissure and the 
calcarine sulcus.  Branches of primary sulci are called seco
se
 between individuals.  Secondary sulci are all present by birth wherea
ntinue to form in the first year postnatally.   
B
ultimate pattern of cortical folding.  A complete failure of cortical folding results in 
lissencephaly which is associated with mutations in genes such as LIS1 and DCX.194  
Specific genetic disorders such as Williams syndrome (7q11.23 deletion) are known
associated with a global increase in gyrification195 and with an anomalous course of the
Sylvan fissure.196  Additionally in normal individuals gyral patterns have been shown t
be more concordant in monozygotic rather than dizygotic twins.197  However, in the latter 
study the heritability of gyral patterns was much less than that found for brain volume 
suggesting that environmental agents have a major role to play in cortical folding.  
Among the environmental factors implicated in disturbances of cortical folding are 










onnecting fibres are drawn closer to 
ach other to form a gyrus by the mechanical tension produced by the fibres.  Certainly 
t 
the cerebral cortex are unknown.  Brain growth is certainly important with the earli
theories of gyrification suggesting that folding of the cortex was a result of cerebral
expansion constrained by the limited space available in the intracranial vault.200  The 
disordered layering of the cortex in lissencephalic brains has led others to suggest th
folding results from differential growth of cortical layers with outer layers growing f
than inner ones and the resulting mechanical tension leading to buckling of the surface
Research also suggests that cortico-cortical and subcortico-cortical connectivity have 
important roles to play in determining the eventual pattern of cortical folding.202-204   It 
has been suggested that cortical regions with many c
e
connectivity between areas in the same gyrus has been found to be greater than tha
between areas separated by a sulcus.202  Others have emphasised that disruption of 
thalamo-cortical fibres leads to an increase in cell death in the developing cortex 
therefore variations in thalamo-cortical connectivity will contribute to differential cortical 
growth and hence regional folding.203,204  Dysconnectivity has been suggested as 
pertinent in the study of both autism205 and schizotypy84 hence the relevance of studying 








4.3  Hypotheses 
 
Examination of schizotypy 
 
Clinical Features 
The schizotypal subjects will have a higher prevalence of clinical features consistent with 
schizophrenia spectrum disorders, in particular delusions and hallucinations 
 
Neuroanatomical Measures 
Compared to the control groups the schizotypal subjects will show: 
1) increased right prefrontal lobe volume 
2) increased right prefrontal gyrification index 
3) increased midsaggital area of the genu of the corpus callosum 
4) decreased midsagittal area of the isthmus of the corpus callosum 
 
 
Examination of PDD 
 
Clinical Features 
he PDD subjects will have a higher rate of clinical features consistent with autism 
ectrum disorders, in particular anxiety, obsessive-compulsive phenomena, slowness 








ompared to the controls, those with PDD will show: 
rain volume 
2) increased prefrontal lobe volume 
 left prefrontal gyrification index 
of schizotypy and PDD
C
 1) increased whole b
 
 3) increased
 4) reduced midsaggittal area of the corpus callosum  
 
 
Examination of comorbidity  
Clinica
In line ere is a group of individuals who 
have fe thesised that 
those c e 
ose with schizotypal features alone but will differ from those with PDD alone. 
ures 
 similar pattern is expected to that hypothesised for the clinical features, i.e. the 
re expected to differ in terms of the brain structural measures from 
 
l Features 
with the idea that among the PDD population th
atures of PDD due to a primary diagnosis of schizotypy, it is hypo















The recruitment process is summarised in figure 5.1.  Recruitment was via schools and 
colleges across 18 out of the 19 Educational Authorities in Scotland which are within 
reasonable travelling distance of Edinburgh (one Educational Authority declined to 
participate).  Of the 273 schools and colleges approached 99 agreed to enter the study.  
The head teachers of these schools were asked to identify adolescents receiving special 
educational assistance, in particular those with a presumed IQ in the range 50-80.  
Exclusion criteria at recruitment were known syndromic learning disability, severe 
cerebral palsy, profound learning disability, lack of speech and a known brain injury.   
 
Parents of the adolescents identified were then invited to participate in the study by letter.  
Five hundred and one individuals initi participate although 64 of these 
subsequently withdrew and a further 42 were excluded on the basis of the criteria above 
leaving a total of 395 subjects.  394 of the 395 were assessed using the Structured 
Interview for Schizotypy (SIS)184 and the Childhood Behavioural Checklist (CBCL)183 
(one participant did not complete the SIS).  Cut-offs on these scales, which were found to 
predict the later development of schizophrenia in the Edinburgh High Risk study,206 were 
used to identify those suitable for recruitment into the next phase of the study for more 
detailed assessment.  The average scores on the SIS and the CBCL were higher in this 
population than in the Edinburgh High Risk Project therefore the cut-off points were 
scaled up appropriately.  Participants were evenly sampled into 4 groups based on these 
cut-offs – SIShighCBCLhigh, SIShighCBCLlow, SISlowCBCLhigh and SISlowCBCLlow.  In 
ally agreed to 
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addition to the subjects receiving special educational assistance a control group 




    
 
 
Summary of the recruitment process 
c
also recruited.  The controls had no history of receiving educational assistance or of 




















138 subjects 42 unimpaired 
siblings of subjects 
20 unrelated 
controls 
99 out of 273 schools and colleges 
501 individuals receiving special educational assistance 
64 withdrawals 
42 exclusions 
1 incomplete assessment 
394 subjects receiving 
assistance 
special educational 
Assessment with SIS and 
CBCL and sampling into 
four groups based on scores 
Siblings and friends of 
subjects approached and 
invited to take part  
18 out of 19 Education Authorities in Scotland 
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The current report concerns the baseline data of the first 200 participants who un
the detailed clinical, neuropsychological and neuroimaging assessments.  They consist of
138 individuals receiving special educational assistance, 42 sibling controls and 20 
unrelated controls.  On IQ tes
derwent 
 
ting it was revealed that two of the unrelated controls had 
s of less than 70 (65 and 69) therefore they were excluded from the study.  In addition 
 sibling controls and 1 unrelated control were excluded as they scored above the cut-off 
or the SIS.  Thus the final number of participants considered in the study is 193 - 138 
dolescents in special education, 38 unimpaired siblings and 17 unrelated, unimpaired 
dividuals.  In order to limit the number of comparisons the siblings and the unrelated 
ontrols were c bined to form one unimpaired control group, with relationships 






















5.2  Assessments 
 
The Structured Interview for Schizotypy (SIS) 
The SIS is an observer rated interview schedule developed by Kendler and validated in 
three separate pilot studies where it was found to reliably distinguish between the 
relatives of patients with schizophrenia and relatives of controls.184  It is divided into two 
main sections – “symptoms” and “signs”; the former takes the form of a semi-structured
interview while the latter is rated by the investigator following the interview and 
encompasses the observed behaviour of the subject.  The items covered in the 
“symptoms” section are social isolation/introversion, sensitivity, social anxiety, ide
reference, suspiciousness, restricted emotion, magical thinking, illusions, psychotic-like 
 
as of 
ymptoms, derealisation/depersonalisation, adult antisocial traits, irritability and 
pulsivity.  Adult antisocial traits was excluded from the current study as the majority 
f the participants were not of sufficient age to be rated.  The main items rated in the 
signs” section are rapport, affect, organisation of speech/thought, odd/eccentric 
ehaviour and suspiciousness.  Individual scores are assigned to each question and a total 
core is generated.  In addition, the investigator allocates a global score of between 1 
marked) and 7 (absent) for each section listed above.  The cut-off in the current study 
elates to a composite score derived from each of the individual sections.  As described 
bove, this cut-off is derived from the results of the Edinburgh High Risk study and 
odified to reflect the generally higher SIS score in intellectually impaired populations.  
t is important to note that the cut-offs while empirically derived, are not diagnostic of a 















schizophrenia; rather it acts simply to allow comparisons to be made between two groups 
ith different degrees of schizotypal features.   











The Social Communication Questionnaire (SCQ) 
Originally named the Autism Screening Questionnaire the SCQ was developed due
perceived need for a reliable and valid screening instrument for autistic spectrum 
disorders.185  It is based on the revised version of the Autism Diagnostic Interview (ADI-
R), one of the most widely accepted standardised diagnostic parental interviews fo
autism.  The SCQ is not a diagnostic interview but is completed by the primary
themselves in the form of a questionnaire.  There are 40 questions answered in a yes/no 
format which are divided into two sections.  The first covers present behaviours while the
second relates to the time when the subject was around 4-5 years old.  The questio
cover the three main areas which make up the diagnostic criteria for autism - reciprocal 
social interaction, language and communication, and repetitive and stereotyped pattern
of behaviours.  Each question scores one point, giving a maximum total of 40.  Th
was validated in a population of 200 individuals with a variety of neurodevelopmental 
disorders including autism, other pervasive developmental disorders (comprising atyp
autism, Asperger syndrome, Fragile X and Rett syndrome) and a variety of other 
disorders which may share some features with autism and which it would important to 
distinguish from autism (such as developmental language disorder, attention deficit 
hyperactivity disorder, learning disability and anxiety disorders).  Two cut-off points 
were derived from this study.  The first (15/40) is used to distinguish individuals with any
pervasive developmental disorder from individuals with other disorders, while the 
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second, higher cut-off (22/40) is used to sub-divide the PDD group into those with PDD-
NOS and those with autism.185   
 
The Clinical Interview Schedule  
The Clinical Interview Schedule (CIS)207 is a semi-structured interview covering a wide 
range of psychiatric symptoms and signs which are rated on a 5 point scale from 0
(absent) to 4 (severe).  Scores of 2 or more are generally regarded as indicating morbid 
levels of symptomatology.  In the current study the modified version which allows fo







208  It is divided into 2 sections – 
reported symptoms and manifest abnormalities.  In the first the interviewer rates the 
subject on their own account of the frequency, duration and intensity of any symptom in 
the past week.  The subjects account is taken at face value with the investigators 
interpretation of the symptoms discounted.  In the second section, manifest abnormalities
the interviewer is expected to apply their clinical judgement in making assessments abou
the subject for each item.  Section 1 includes somatic symptoms, excessive concern with 
bodily functions, fatigue, sleep disturbance, lack of concentration, irritability, depressio
depressive thoughts, elation, anxiety, phobias, obsessions and compulsions, and 
depersonalisation.  Section 2 includes observed slowness, suspiciousness, histrion
behaviour, depression, agitation, elation, flattening of affect, delusions, hallucinations, 






5.3  Division of Subject Groups 
 
In order to examine the clinical and brain structural characteristics of the participants 




n in the 
he SCQ cut-offs distinguish three groups – autism, PDD-NOS and subjects who show 
o signs of PDD.  Thus this section concerns 4 groups – autism, PDD-NOS, educational 
ontrols and unimpaired controls.  It should be noted that no SCQ result was available for 
with respect to autistic and schizo
as a whole but then divided into groups depending on their scores on the SIS and the 
SCQ.  For each scale there is a group of subjects receiving special educational assistan
who do not score above the cut-offs.  In the analyses which follow these subjects form a
second control group which can be considered analogous to “psychiatric” control groups 
sometimes used in other research.  The term “educational” controls is used to describe 
this group.  It should be noted that the educational controls will differ depending on w
scale has been used to divide the subject group.  For each analysis the same group of 
unimpaired controls is used.   
 
Division of subjects based on SIS 
The SIS cut-off divides the subjects into two groups – those above the cut-off (hereafter 
referred to as SIS+) and those below the cut-off (educational controls) as well as the 
unimpaired controls.  The demographic characteristics of these groups can be see
appropriate section of the results (Table 6.3). 
 






three of the subjects as they were either adopted after the age of 5 or in foster care.  The 
emographic characteristics of the SCQ groups can be seen in the appropriate results 
 
d
section (Table 6.6)   
 
Division of subjects based on both SIS and SCQ 
In an attempt to examine issues of comorbidity between schizotypal and autistic features 
the subjects were split into 6 groups as shown in Table 5.1 and the unimpaired controls.  
The demographic characteristics of these groups are also shown in the appropriate section
of the Results (Table 6.9). 
 
Group determined by SIS 
 
SIS+ SIS- 
Autism Comorbid Autistic “Pure” Autistic 
PDD-NOS Comorbid PDD-NOS “Pure” PDD-NOS 
Group 
“Pure” SIS+ Educational Controls 
determined 













5.4  MRI scanning 
 
Acquisition 
MR imaging was performed at the SHEFC Brain Imaging Research Centre for  
GE Medical Systems, Milwaukee, 
ence with parameters of 3.3/8.1/1, TI 600, flip 15, slice 
ickness 1.7 mm (no gap), matrix 256×192, FOV 220 mm.   
 
Whole Brain Volume 
T in  deri ated met
pr ere ver a native space brain tissue mask se 
s were dilated to recover whole brain volumes inclusive of cortical and sub-
.  The dilation process, implemented in a Matlab function, was allowed to 
ains were hand edited using Analyze 5.0 to give the 
s based.  The final whole brain volume 
 the total grey and white matter excluding ventricular CSF.  On average each 
Scotland on a 1.5T GE Signa Echospeed system (
Wisconsin) operating in research mode consisting of a T1-weighted sagittal sequence 
with parameters of 16/450/0.75 (TE/TR/excitations) and a T2-weighted axial sequence 





 volume was ved using a semi-autom hod. SPM 99 
 for each brain.209  The used to reco
tissue mask
cortical CSF
overrun and these over-dilated br
brain volumes upon which the analysis wa
consisted of







To account for inter-individual differences in the exact location and orientation of the 





minutes per scan.   
head when s
midpoints of the anterior and posterior commisures were identified on the most s
axial slice on which they were visible.  A third point superior to the anterior commisu
lying in the interhemispheric fissure was then identified and the images were resection
using the plane formed by these three points as the midsagittal slice.  The corpus 
callosum was outlined on this slice and divided into 7 sub-regions as outlined by 
Witelson189 and shown in Figure 5.2 with the corresponding cortical regions in brac
The average parcellation time for the corpus callosum was 15 
 
Figure 5.2 
Corpus Callosum subdivided as per Witelson (1989)189 
Sub-regions labelled as below with corresponding cortical region in brackets 
r = rostrum (orbital prefrontal, premotor), g = genu (prefrontal), rb = rostral body 
remotor, supplementary motor), am = anterior midbody (motor), pm = posterior 
idbody (somaethetic, posterior parietal), i = isthmus (superior temporal, posterior 
 (inferior temporal, occipital) 
Adapted from Hardan et al (2000)117 
(p
m
parietal), s = splenium
96 
 





brains are preprocessed using SPM 99 functions.   They are segmented into grey and 
white tissue, reorientated in native space along the AC-PC axis and resliced to give 
voxels of size 1mm x 1mm x 1mm.  Next the tool reads in the manually set anterior limit 
of the corpus callosum and detects the interhemispheric fissure thus splitting the lobes.  
The inner contour is then traced along the entire surface of the brain including into each 
sulci.  Buried sulci (i.e. those that do not communicate directly with the cortical surface 
on that particular slice) are also included.  The outer contour, in accordance with Zilles et 
 is determined by rounding the exposed surface of the brain, essentially 
g this rounded contour.  The 
 
The prefrontal lobe volumes and gyrification index were determined using the previous
extracted whole brains and applying a new automated method which allows the 
computation of the gyrification index (aGI).211  The posterior limit of the prefrontal lobe 
was the first coronal slice in which the genu of the corpus callosum becomes visible 
moving caudally.  Normally the aGI tool detects this slice automatically however this was
not possible in this cohort, probably as a result of reduced white matter integrity o
corpus callosum, therefore it was set manually.   
 
Briefly, the aGI tool works through several stages.  First, the previously extracted 
al (1988),212
filling in the troughs between gyral peaks, and measurin
results are then exported and the gyrification index calculated by dividing the inner by the 
outer contour.  The prefrontal grey and white matter volumes derived from the SPM






Example of an aGI trace 
 
Reliability Studies 
Two investigators carried out the tracing of the whole brain volume and the corpus 
callosum.  For the purposes of establishing intra-rater reliability each investigator traced 
ten randomly selected scans twice.  A further twenty scans were traced by both 
investigators (10 at the beginning of the study and 10 at the end) to establish inter-rate
reliability.  The intra-class correlation coefficients were calculated and ranged between 







5.5  Statistical Analysis 
 
All statistical analyses were carried out using SPSS 14.0 for Windows.  There were four 
parts to the analysis.  Part 1 considered the subjects in special education as a whole; part 
2 examined the subject groups formed by the SIS cut-offs; part 3 concerned autistic 
features using the groups determined by the SCQ cut-offs; part 4 examined comorbidity 
and concerned the groups derived by using by the SIS and the SCQ to divide the subjects.  
In all analyses concerning neurostructural measures the effects of age and gender were 
controlled for.  IQ was included as a covariate in part 1 but not in parts 2-4 as the use of 
the educational control group accounted for IQ.  When the unimpaired control group was 
included in the analysis the sibling relationships between subjects and controls were 
or by the use of a pedigree variable which is essentially an identifier allocated 
en analysis of covariance (ANCOVA) was used standardised 
sidual plots were checked to ensure the appropriateness of the test.  As there is little 
pulation group so that this study is of a preliminary nature no attempt 
 
ects of age, gender and IQ.   
accounted f
to each family group.  Wh
re
known about this po
has been made to correct for multiple comparisons.   
 
Part 1 – All subjects in special education 
The correlation between the SIS and the SCQ was examined using Pearson’s r then 
relationships between the neurostructural measures and the SIS and SCQ were examined





Parts 2 to 4 – Subject group divided by SIS (part 2), SCQ (part 3) and both (part 4) 




rately to look for associations between the 
es 
.  For those 
easures which were normally distributed ANCOVAs were used with the structure as the 
ependent variable, symptom and gender as fixed factors and covarying for age.  
G
chi2 with Fishers exact test used when more than 20% of the cells contained less than 5 
individuals.  When the overall chi2 was significant, examination of the standardised 
residuals was used to determine which cells produced the significant result.   
 
Group differences in the structural measures were analysed using multiple ANCOVAs 
with the structure in question as the variable, group and gender as fixed factors, pedigre
as a random factor and age as a covariate.  When a main effect of at least trend level 
significance (p<0.1) was found post hoc between-group comparisons were carried out.  
The analyses were repeated, first with the addition of height as a covariate and then, f
the callosal measures, with the addition of whole brain volume to the analysis to 
determine if the size differences identified were proportionate to an increase in the 
overall brain volume.  In addition the appropriate prefrontal lobe volume was added as 
covariate to the GI analyses to determine if differences in the GI reflected prefrontal 
volume differences or other factors.   
 
Exploratory analyses were carried out sepa
structural measures and symptoms.  Only the subject groups which showed differenc
from the controls on both symptoms and brain structure were included and only those 





Standardised residual plots were checked for each ANCOVA.  For those which were not 
 
normally distributed a Mann-Whitney test was used.  Note that the Mann-Whitney test 

























6.1  Part 1 – Whole Group 
 
Demographic and Clinical Features of subjects and controls 
The demographic characteristics, IQ and mean scores on the SIS, CBCL and SCQ of the 
subjects in special education and of the controls are shown in Table 6.1.  The results for 
the CIS are given in Table 6.2.  In general the subjects score more highly than the 
controls on measures of psychopathology although the controls do have significantly 
higher rates of phobic anxiety.  Note that data for the controls are provided for reference 
only to allow the reader to gain some sense of the overall characteristics of the subject 
group; no investigation of the relationship between brain structure and symptoms are 
included here as the heterogeneity of the subject group makes interpretation difficult at 
this stage.   
 
 Subjects Unimpaired Controls 
N 138 55 
Gender (M:F) 85:53 28:27 
Age 15.8 (1.6) 16.9 (2.1) 
Height 166.6 (8.6) 167.6 (8.8) 
IQ 72.7 (16.7) 100.9 (15.4) 
SIS 30.9 (10.7) 18.7 (5.7) 
CBCL 79.0 (34.8) 25.2 (21.9) 
SCQ 14.2 (6.5) 5.5 (2.1) 
Table 6.1 













Morbid 13.9 9.3 
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Absent/Mild 97.8 100 0.56 






Incoherence of speech 






Poverty of Speech 







ani alities as m IS in subjects 
and co
Results are given as percentages of total group 





Frequency of symptoms and m fe t abnorms easured by the C
ntrols 




Continuous relationships between SIS, SCQ and neuroanatomical variables within the 
participants receiving special educational assistance 
 
There was no evidence of a correlation between the SIS and the SCQ (r=0.04, p=0.62). 
 
e 
There were no significant correlations between any region and total SIS score after 
cova  and gender, alt  there was a tren ards a weak posi
 score and b e (r=0.17, p=0.06).  The addition of IQ as 
a cova e no difference to esults.   
 
e 
Significant correlations were found between total SCQ and the size of the rostral body 
and body of the corp llosum after covarying for age and gender (r=0.19, 
p 0.02 respecti sitive 
correlation between the rostrum size and SCQ (r=0.17, p=0.06).  Again, the addition of 
SIS and SCQ 
SIS and brain structur
rying for age hough d tow tive 
correlation between SIS rain volum
riate mad the r
SCQ and brain structur
posterior mid us ca
=0.04 and r=0.21, p= vely).  There was a trend towards a po








6.2  Part 2 - Schizotypy 
 
Description of Groups 
hic characteristics, mean IQ and mean scores on the SIS, CBCL and SCQ 
ontrols had a significantly higher mean IQ and lower SIS, CBCL and SCQ scores than 
tantly there were no differences between the SIS+ subjects and 
ortion 






of the three groups are shown in Table 6.3.  As would be expected the unimpaired 
c
the other groups.  Impor
the educational controls on IQ, SCQ or CBCL.  The unimpaired controls were 
significantly older than the other two groups (F=7.7, p=0.01) and had a higher prop
of females (although this did not reach statistical significance - chi2=2.69, p=0.26).   
 
N 72 66 55 
Gender (M:F) 47:25 38:28 28:27 
Age 15.8 (1.7) 15.8 (1.5) 16.9 (1.8) 
Height 167.3 (8.1) 165.9 (9.1) 167.6 (8.9) 
IQ 74.4 (17.7) 70.9 (15.5) 100.9 (15.4) 
SIS 37.9 (7.7) 21.5 (5.9) 18.7 (5.7) 
CBCL 78.3 (33.3) 79.8 (36.6) 25.2 (21.9) 
SCQ 14.0 (6.9) 14.3 (6.0) 5.5 (2.1) 
Table 6.3 
Demographic characteristics and mean IQ, SIS, CBCL and SCQ scores of participants by 
roup 








The CIS symptom categories for each of the groups are summarised in Table 6.4.  






The results for the region-of-interest and gyrificatio parisons ar sed 
in Table 6.5.  The mean values for each, adjusted for age, gender and pedigree are given, 
as are th n effects (F) an nce (p) of the ANCOVAs.  The between group 
comparisons are given for those results where the m howed at l
towards significance (i.e. when p<0.1).  Results for the between group comparisons are 
given i al column with those which only sh towards si
given in brackets. 
 
Significant differences 
experiencing the highest degree of psychopathology.  Compared to the educational 
controls and the unimpaired controls the SIS+ group had a higher prevalence of mo
fatigue, irritability, depression, depressive thoughts, anxiety, obsessions and compulsions
slowness, suspiciousness, delusions and hallucinations.  Differences which exist between
the SIS+ subjects and the unimpaired controls but which are not seen between t
and the educational controls are likely to relate to IQ rather than schizotypal status – an 
example of this would be lack of concentration.   
 
n index com e summari
e mai d significa
ain effect s east a trend 





























































Absent/Mild 73.2 87.9 94.4 
5.6 
0.003 
















































5 Absent/Mild 71.8 87.9 83.3 0.0
Phobias 
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Adjusted r the regions o est and gy ion index 
ean (SE). 
llosum and 
†p=0.02, (0.09); ††p=0.02; ‡p=0.02 
le 6.5 
 means fo f inter rificat
Results are given as m
Units are mm3 for whole brain and prefrontal volume and mm2 for corpus ca
sub-regions.   
Between group comparisons in brackets are trend level significance (<0.1) 





The SIS+ subjects had a larger me we nlar me
r lobe, p ly the atter co to b n roups
 only a t nd versus the nimpaired controls.  In addition the SIS+ 
group had a significantly sm  than the educational controls and a 
smaller isthmus of the corpus callos  un nt i ilar but
non- ant diffe  for ntr ea e re w
significan ifferences o
gyrification index on either side.   
 
The addition of whole brain volume as a c
agai  groups d  e o  of the 
cal did not affect the results.   
 
Relationship between abnormal neurostructural measures and symptoms in SIS+ group 
D ughts iate ger 3.9 0 nd ther
was a trend for anxiety to be associated w
lthough the numbers were very small (4 vs. 59) necessitating the use of non-
had a significantly 
 callosum.  (Z=2.28, p=0.02).  There were no 
ons between symptoms and the abnormal brain structural measures.     
 
an brain volume and also sho d e ge nt of the 
ight prefrontal articular white m mpared oth co trol g , 
although this was re  u
aller callosal rostrum
um than the impaired co rols w th sim  
signific rences seen  the other co ol group in ch cas .  The ere no 
t d bserved for the other callosal regions or for the prefrontal 
ovariate made the isthmus result significant 
nst both  of controls but otherwise ha  no significant ffect n any
losal results.  Similarly the addition of height as a covariate 
epressive tho  were assoc d with a lar isthmus (F= 2, p= .05) a e 
ith enlarged right prefrontal lobes (F=3.08, 
p=0.08).  A
parametric statistics, people with morbid levels of suspiciousness 






6.3  Part 3 – Pervasive Developmental Disorders 
 
 





The demographic characteristics, mean IQ, SCQ, SIS and CBCL scores of the four 
groups defined by the SCQ cut-offs are shown in Table 6.6.  The controls had a 
significantly higher mean IQ than each of the other three groups and were significantly
older than the autism and educational control groups.  There were no significant 
differences between the autism, PDD-NOS and educational control groups with respect to
SIS score.   
N 23 35 77 55 
Gender (M:F) 18:5 22:13 42:35 28:27 
Age 15.7 (1.6) 16.3 (1.8) 15.7 (1.5) 16.9 (1.8) 
Height 167.9 (11.2) 167.1 (9.5) 165.8 (7.1) 167.6 (8.9) 
IQ 69.4 (17.2) 73.7 (19.3) 73.7 (15.5) 100.9 (15.4) 
SCQ 24.9 (2.6) 17.4 (1.7) 9.5 (3.1) 5.5 (2.1) 
SIS 29.2 (8.9) 31.6 (12.4) 30.0 (10.6) 18.7 (5.7) 
CBCL 98.2 (38.2) 93.7 (29.3) 66.0 (30.6) 25.2 (21.9) 
Table 6.6 




The CIS scores for each of the four groups are shown in Table 6.7.  Significant 
differences were seen between the groups for sleep disturbance, concentration, 
depression, obsessions and compulsions, slowness, observed depression, hallucinations 
and poverty of speech.  The autism group showed increased rates of slowness and 
113 
 
poverty of speech compared to any of the other groups and both the autism and PDD-
OS groups had poor concentration.  For the remainder of the symptoms it was the PDD-
   
o each 
he genu of the corpus callosum was significantly smaller in the autism and 
the PDD-NOS groups relative to the educational controls  trend towards a 
reduction for the autism group when compared to the unimp ols.  The rostrum 
and the rostral body of the corpus callosum were larger in the autism and the PDD-NOS 
group ive to the  contro this was d for t
in the  PDD-NOS group and the rostral body in the autism 
 
When whole brain volume was added as a cova
effect for the rostral body result became  The ad ight a  
ect the results significantly.   
en abnormal neurostructural measures and symptoms in autism and 
l body of 
N
NOS group who were particularly morbid, especially with respect to hallucinations.
 
Neurostructural Measures 
The autism group showed significant reductions in right prefrontal GI compared t
of the other three groups.  There were no significant differences in other prefrontal lobe 
measures.  T
and there was a
aired contr
s relat educational ls although  only a tren he rostrum 
group.     
riate to the callosal measures, the main 





There was a trend for poverty of speech to be associated with an enlarged rostra
the corpus callosum in the autism group (F=3.42, p=0.08).  No other symptom-structure 
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Controls F P 
Between 
oup tests(1) ) s (3)
  
(4) gr  
Who 1297.1 1287.5 (37.7) 1352.8(19.4) 
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.6) .4) ) 2.24 1, ** 
††1,2<3
(4.8) .6) ) 2.28  (1),2>3
3.1) .7) ) 
 (9.5) 5.2) 3) 1.15 
Table 6.8 
Adjusted means for the regions of interest and gyrification index 
Results are given as mean (SE) and units are mm3 for whole brain and prefrontal volume 
up comparisons in brackets are trend level significance (<0.1) 
p=0.02, <0.006, 0.03; **p=0.04, 0.06; ††p=0.02, 0.04; ††p=0.06; ‡p=0.07, 0.04 






6.4  Part 4 - Comorbidity of Schizotypy and Pervasive Developmental Disorders 
Characteristics of Subject Groups 
emogr ara  with an IQ, Q an C res for 
iven in Table 6.9.  There were significant differences in gender 
d age be rou eigh paired controls had a higher mean 
 but the sign iffer en ou l
ote that t d PD d a  hi or  a  the 
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each of the groups are g
an tween the g ps but not h t.  The unim
IQ re were no ificant IQ d ences betwe the other gr ps.  C early 
differences will exist in SIS and SCQ score between the groups but it is interesting to 
n he comorbi D group ha significantly gher SIS sc e than ny of




 PDD-N S Con
N 13 17 42 10 18 35 55 
M: 11:2 :5 18  :8 : 7 F 12 24: 7:3 10  18 17 28:2
A 5.8 (1.9  (1.7 (1.7 (1.2  (2  (1.2 .9 (2.1) ge 1 ) 16.1 ) 15.7 ) 15.6 ) 16.4 .0) 15.7 ) 16
H .9 (9.1  (8.8  (7.6 (13  (9 1 (6.5) 167.6 (8.9) eight 167 ) 169.3 ) 166.4 ) 168.0 .9) 165.1 .9) 165.
IQ 70.7 (20.3 (19.6 16.3 12. (19  (14.7) 100.9 (15.4) ) 76.5 ) 74.8 ( ) 67.6 ( 8) 71.1 .3) 72.4
S 5.4 (4.8  (9.1 (7.6 (6.1  (7  (5.6) 18.7 (5.7) IS 3 ) 41.2 ) 37.4 ) 21.2 ) 22.6 .0) 21.0
CB .3 (26 28 26. 50 25  (34.3) 25.2 (21.9) CL 95 .7) 105.4 ( .7) 62.1 ( 9) 102.0 ( .8) 82.7 ( .9) 70.7
SCQ 25.4 (3.2) 17.5 (1.6) 9.2 (2.9) 24.2 (1.7) 17.3 (1.8) 9.9 (3.3) 5.5 (2.1) 
Table 6.9 
Demographic characteristics, mean IQ, SIS, CBCL and SCQ scores of the subject and control groups 







The CIS symptom categories for each group are shown in Table 6.10.  The comorbid 
morbid group in terms of not only general symptoms 
y did 
he comorbid 
utism group also scored highly for slowness.  Neither were particularly morbid on other 
m lud c symptoms when compared to the other groups.
 
Neurostructural data
T f th s fo s of d the wn 
6 D sho tio gr  ma
right prefrontal lobe relative to alm
N  Si nd  t  s em
r tal l uctio ize o al ro ive to
allosum relative to the control 
roups.   
PDD-NOS was the most strikingly 
such as fatigue and irritability but also more specific symptoms including depressive 
symptoms, obsessive-compulsive behaviour, delusions and hallucinations.  The SIS+ 
group were more anxious than any of the other groups and showed increased rates of 
delusions and hallucinations similar to the comorbid PDD-NOS group although the
not have the same degree of other symptomatology.  In contrast the PDD-NOS group 
were not particularly symptomatic as measured by the CIS.  Both the autism and the 
comorbid autism groups showed morbid levels of poverty of speech and t
a
easures inc ing psychoti    
 
he results o e ANCOVA r the region  interest an  GI are sho in Table 
.11.  The PD -NOS group wed a reduc n in both the ey and white tter in the 
ost all the other groups including the comorbid PDD-
OS group. milar to the fi ings in Part 2 he SIS+ group howed enlarg ents in the 
ight prefron obe and red ns in the s f the callos strum relat  the 
control groups.  The autism group showed a trend towards increased right prefrontal grey 






Neurostructural Measures with respect to symptoms 
Morbid levels of anxiety in the SIS+ group were associated with increased prefrontal lobe 
measures particularly on the right side (total prefrontal lobe – F=6.89, p=0.01; right 
prefrontal lobe – F=7.12, p=0.01, right prefrontal GM – F= 6.40, p=0.02; right prefrontal 
WM – F=6.62, p=0.02).  No other structure-symptom relationships were seen in those 
groups that had both morbid symptomatology and brain structural differences relative to 
controls.    
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7.1  Schizotypy 
 
Clinical Findings 
It is clear from the findings on the CIS that the SIS cut-off does indeed identify a group 
with a high degree of schizotypal psychopathology.  Particularly striking are the high 
rates of delusions and hallucinations in the SIS+ group (17.1% and 28.6% respectively).  
In contrast, these symptoms are much rarer in either of the control groups.  All of the 
subjects were derived from a non-clinical population and although they did have scores 
within the range considered morbid on individual psychotic symptoms, none of the SIS+ 
group were considered to be suffering from an actual psychotic illness at the time of 
assessment.  Observed slowness at interview is another symptom which was virtually 
absent in the control groups but is present to a morbid degree in a significant proportion 
of the SIS+ group (18.6%).  A look a res reveals that the majority of 
those rated as morbid were felt to be apathetic and lack spontaneity as opposed to 
suffering from true psychomotor retardation.  It is likely that the morbid levels of 
slowness represent part of the negative dimension of schizotypy analogous to negative 
symptoms in schizophrenia.   
 
High rates of obsessive-compulsive symptoms are also seen in the SIS+ group.  Although 
not part of the diagnostic criteria obsessive symptoms are frequently seen in 
schizophrenia213,214 and have been found to be associated with schizotypal personality 
traits.215,216  In particular those obsessive thoughts which are highly unrealistic and 
considered by the individual to be threatening in their own right are thought to be 
t the raw CIS sco
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associated more with schizotypal personality disorder than obsessive-compulsive disorder 
s opposed to those obsessions in which it is the consequences which are considered to 








d expect in normal adolescence, however were present to a 
reater degree in the schizotypal individuals.  Again this is in agreement with the 
ariables 
(a
be unpleasant).217  
obsessional ideas from overvalued ideas and even delusions.  Interest in the link between 
obsessive-compulsive disorder and schizophrenia has increased in recent years with so
proposing that there exists a subtype of schizophrenia with prominent obsessive 
symptomatology.218  Cortical regions which have been found to be abnormal in OCD 
centre around the orbitofrontal cortex and the frontostriatial network, both of which have
also been implicated in schizophrenia.219,220  In addition there are important reciprocal 
modulatory effects between the serotonin and dopamine systems221 which are felt to b
primarily responsible for OCD and schizophrenia respectively.  Further evidence for th
is seen in Tourette syndrome which is frequently comorbid with OCD and is treated with
dopamine antagonists, leading some to suggest a dual role for serotonin and dopamine
the pathogenesis of OCD.222     
 
Symptoms such as anxiety and depression were reported reasonably often in the control
populations much as one woul
g
literature regarding comorbidity in schizophrenia and schizotypy.223   Interestingly in the 
Edinburgh High Risk Study anxiety and depression were among the clinical v
which best predicted the later development of schizophrenia although it is not known 
whether such non-specific affective phenomena represent part of the causative 
mechanism or are secondary occurrences.224   
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Neurostructural Data  
The reported results are consistent with hypotheses 1 and 4 but not 2 or 3.  The SIS+ 
group showed an overall increase in brain volume and right prefrontal lobe volume 
(hypothesis 1), especially the right prefrontal white matter.  No size differences were 
present when the remainder of the brain was considered, suggesting that the prefrontal 
enlargement is not part of a generalised enlargement of the entire brain.  This fits
observed reduction in the isthmus of the corpus callosum (hypothesis 4) which contain
fibres originating in the temporal lobe, whereas the rostral size reductions suggest that 
within the prefrontal lobe itself the enlargements may not be uniform.  Within the 
schizotypal subject group a smaller isthmus was associated with morbid levels of 
suspiciousness, while a larger one was associated with an increase in depressive thoughts.
Morbid levels of anxiety were associated with enlarged right prefrontal white matter.  
Contrary to hypotheses 2 and 3 no significant differences in the size of the callosal genu 
or in prefrontal GI were seen be
 with the 
s 
  




callosal rostrum reported in the current 
 
In the largest structural MRI study of the prefrontal lobe in schizotypal personality 
disorder Suzuki et al found enlargements of the middle frontal gyrus and reductions in the 
right straight gyrus compared to controls.54  The middle frontal gyrus makes up a l
part of the lateral prefrontal cortex while the straight gyrus is a relatively small structure 
which lies on the ventromedial aspect of the prefrontal lobe abutting the orbitofrontal 
cortex.  If a sufficient degree of enlargement is present in the middle frontal gyrus it is
likely to obscure any reductions in the smaller straight gyrus when the total pref
volume is considered.  The reduced size of the 
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rostrum carries fibres which originate in the orbitofrontal cortex.  A reduction in the 
posterior corpus callosum has also been previously reported in schizotypal personali
disorder60 and is consistent with findings of reduced temporal lobe volumes in 
schizotypal individuals.57,61   
 
The lack of a significant difference in the size of the callosal genu (hypothesis 3) is 
contrary to the one previous study which has examined the size of the corpus callosum 
schizotypal personality disorder.60  A non-significant enlargement of this region wa
between the SIS+ group and the educational controls.  It is possible that population
differences account for the disagreement between the current study and previous work as 
the subjects considered here were younger.  The corpus callsoum has been shown to 
continue development beyond adolescence225 and it is possible that significant difference
between the groups may emerge with time.     
 
Contrary to hypothesis 2 no difference in prefrontal GI was seen between the groups
increase in right prefrontal GI was reported in the EHRS in high risk subjects who later 
went on to develop schizophrenia compared to those who did not.83  While a significant 
minority of the the SIS+ group considered here are expected to go on to develop 
schizophrenia the majority will not.  The negative finding in this group suggests that an
increase in right prefrontal GI is not a marker for schizotypy, but may instead be 




Within the schizotypal sub-group those with a morbid level of anxiety possessed more 
right prefrontal white matter than those without.  As mentioned above anxiety has bee
found to be an important predictor of the later development of schizophrenia.
n 
l 
t it is 
eed this is one of the premises on which the 








bnormalities are known to occur,229,230 this process has been unable to keep up with the 
224  Not al
of the schizotypal subjects in this study will go on to develop schizophrenia, bu
probable that a significant minority will.  Ind
E
white matter suggests that those schizotypal individuals with more white matter have
worse prognosis than those without.  There are two possible explanations for this.  Firstly 
it is possible that an increase in right prefrontal white matter is in fact detrimental to the 
subjects and rather than protecting against schizophrenia it lies on the causative path
However, if this was the case one would expect to see increases in the prefrontal volume 
in schizophrenia, which is not the case,226 and the evidence of compensatory prefront
function in schizotypal personality disorder would not be seen.  The second possibility is 
that the prefrontal white matter actually undergoes a relative expansion in the schizotypal 
g
early stages of psychosis, which in turn may be the result of evolving temporal lobe 
deficits.  One possible mechanism for this would be an increase in myelination in the 
prefrontal lobe.  There is evidence that axonal activity promotes oligodendrocyte 
precursor cell proliferation227 and that myelination in the prefrontal lobe continue
the third decade.228  If parts of the frontal lobe are required to increase their function to 
compensate for structural abnormalities elsewhere this could lead to an increase in




developing temporal lobe abnormalities and eventually fails altogether leading to the 
more severe clinical picture.   
 
The reduction in the cross-sectional area of the isthmus is consistent with the idea that
temporal lobe abnormalities are important in the pathogenesis of schizotypy.  A morbid 
level of suspiciousness was associated with a small isthmus although the reliability of th
result is limited by the small number of subjects who fell into this category.  The 
temporal lobe is involved in several different aspects of social functioning, including 




231,232  Deficits in either of these processes 
may lead to the misinterpretation of others motives and hence suspiciousness.  Harder to 
explain is the finding that depressive thoughts are associated with a larger isthmus in the 
SIS+ group, particularly when depressed mood was not.  Some studies have found an 
increased size of the posterior corpus callosum in depression, particularly in those with a 
family history of mood disorder and it has been suggested that this represents anomalous 
lateralisation and therefore emotional processing abilities.233,234  It is unclear why the 
direction of the association is opposite to that of the group difference between the SIS
subjects and the controls and the possibility of a Type 1 error should be considered.   
 
In summary the results for the SIS+ group are in keeping with studies in schizotypal 
adults of normal IQ, with an enlargement of the prefrontal lobe, a reduction in the 
callosal rostrum which suggests these enlargements are not uniform throughout the 
prefrontal lobe and reductions in the posterior callosum consistent with temporal lobe 
structural abnormalities.  These findings are supportive of the view that in schizotypy the 
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prefrontal lobe acts to buffer temporal lobe changes and hence prevent deterioration in
schizophrenia.  The relationshi
to 
p between anxiety and prefrontal lobe volume suggests 
at dynamic changes in this region may occur in response to the early development of 
.   
th






















7.2  Pervasive Developmental Disorders  
 
Clinical Findings 
The most striking finding from the CIS data is the high prevalence of morbid 
psychopathology in the PDD-NOS group when compared to the autism or control groups.  
s hypothesised the autism group had a higher prevalence of symptoms which could be 
ssociated with autistic features including slowness, poverty of speech and affectual 
congruity but they had noticeably low levels of other symptoms compared to the PDD-
OS group, and were generally not different from the educational controls in this respect.  
n itself this finding of relatively low rates of psychiatric symptoms which do not relate 
irectly to autistic features is not surprising – after all the CIS is a measure of psychiatric 
ymptomatology, not of social and communication difficulties.  However, the high 
ymptom prevalence in the PDD-NOS group, in the absence of such morbidity in the 
utism group, suggests that the PDD-NOS group is so affected for a reason other than 
eir PDD.  As discussed in chapter 1 PDD-NOS represents a more heterogeneous 
ondition than autism and it is possible that within this group there are sub-groups, some 
f which may have high rates of psychopathology as they are not actually suffering from 
DD but other conditions which have diagnostic overlaps.  One possibility is schizotypy 
nd this issue will be considered further in the section 7.3.   
eurostructural Features 
he results of the region-of-interest analysis allowed only for the partial acceptance of 





















reduction in the corpus callosum, specifically a decrease in the size of the genu.  
owever trends towards an increase in the rostrum and rostral body were also observed, 








f what is known about PDD.  
hile it is commonly accepted that larger structures equate to better function this 




with the increased 
group.  Contrary to hypotheses 1 and 2 there were no differences seen in the w
volume or prefrontal volume for the autism or PDD groups and in direct contrast to 
hypothesis 3 the autism group had a significantly reduced right prefrontal GI compared to
the control groups.   
 
The genu reduction is consistent with previous research,117 but the enlargements of the 
rostrum and rostral body are not.  It should be borne in mind that the division of the genu
from the anterior border of the rostral body is made using the same line which 
distinguishes it from the rostrum (see Figure 5.2).  Movement of this line anteriorly 
thus produce a reduction in the size of the genu and an increase in the size of the rostru
and rostral body, i.e. the pattern which is observed here.  Such an anterior shift could b
the result of shape differences in the corpus callosum, specifically a greater inner cu
rather than size differences per se.   
 
If however the differences reported here represent true size differences in these sub-
regions then the meaning must be considered in the context o
W
relationship may not be so 
both increases and decreases in the size of brain structures are associated with autism an
indeed that this relationship may change over time.  There is no evidence to support t
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existence of compensatory-type hypotheses such as that discussed above for schiz
disorder in autism thus it is possible that both the enlargements and the reductions of the 
callosal sub-regions reported here relate to functional deficits.   
 
The rostrum carries fibres which connect the orbitofrontal cortices (OFC) in opposin
hemispheres, thus the size difference in the rostrum may represent structural 
abnormalities in this 
otypal 
g 
brain region.  The OFC is involved in impulse control and response 




frontal cortex in each hemisphere.  Increasing 
terest has focused on the premotor region in autism due to the finding that neurones in 
 
p
circuit.  This circuit is involved in social behaviour through the perception of social cue
which is the role of medial temporal structures such as the amygdala, and the appropriate 
choice of behavioural response which is the role of the OFC.235  Functional abn
in the orbitofrontal-medial temporal circuit have been reported in autism and are likely to
relate to the social deficits which characterise the disorder.236   
 
The rostral body of the corpus callosum primarily connects the premotor and 
supplementary motor regions of the 
in
this area are activated during both facial affect production and observation.  It is 
hypothesised that the activation of these mirror neurones is due to the internal 
representation or mental imitation of another’s expression as part of the process of 
correctly identifying the displayed affect.237  A lack of activation of mirror neurones in
the premotor cortex has been found in autistic individuals during observation and 
imitation of emotional facial expression suggesting that dysfunction in this system may 
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have a role to play in the deficits in emotional recognition seen in PDD.238  Another 
reason for an enlargement of the rostral body in autism is suggested by the observed 
association with poverty of speech.  Broca’s area is a key region in the production of 




ation was seen.  This 






Alterations in the laterality in this region have been found to be associated with languag
impairment138 and it is possible that this may manifest as an increase in interh
fibres which pass through the rostral body.  In addition, mirror neurones are thought to be
involved in learning speech through imitation and are found in Broca’s area.239  If the 
rostral body enlargement is associated with mirror neurone dysfunction in the premotor 
area and these abnormalities extend to Broca’s area this may also explain the observed 
association.   
 
In contrary to hypothesis 3 a decrease in right prefrontal gyrific
d
prefrontal lobe.120  The difference in results may relate to methodological diffe
between the studies.  The current report considers GI across the whole prefrontal lo
whereas the previous report examined one coronal slice just anterior to the corpus 
callosum.  GI values may differ markedly between slices therefore a single slice e
may not reflect the cortical folding pattern across the whole prefrontal lobe.   
 
The right prefrontal hypogyrification in the autism group and the reduction in the area o
the genu in both the PDD-NOS and autism groups are likely to relate to deficits in 
executive function which have been frequently reported in PDD.27  The reduction in GI 
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seen in the autism group occurs in the absence of volume reductions, suggesting it is 
independent of cortical growth.  In fact a non-significant increase in prefrontal volum
was seen in the autism group therefore the low GI is likely to reflect aberrant prefronta
connectivity, consistent with the reduction in genu size.  As discussed in section 4.2 van 
Essen proposed that closely connected cortical regions will be attracted closer together 
due to tension exerted along neuronal axons leading to those with fewer interconnections 
remaining spatially more dispersed.  Thus, in autism it is possible that less local 
interconnectivity has led to less tension and hence less folding.  However, one would 
expect a reduction in prefrontal white matter volume to accompany the reduction in GI if
there were fewer axonal fibres running between regions.  An alternative explanation is 




relative overconnectivity between regions which are usually poorly 





onnectivity which must occur.   
whole 
c
and hence leads to a reduction in cortical folding.  Such overconnectivity is consisten
with the idea that a larger less well organised brain may lead to the poor co-ordination o
brain regions required to accomplish complex tasks such as language and social 
interaction.167  Interestingly the PDD-NOS subjects did not show the GI reduction 
observed in autism and instead displayed a (non-significant) reduction in prefrontal
volume.  It is possible that such a volume reduction may also lead to autistic features but 
for the more severe phenotype to become manifest it is disordered, rather than
c
 
There were no significant differences found between the groups with respect to the 
brain or prefrontal volumes.  This disagrees with the findings of the meta-analysis 
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reported in Chapter 3 in which autistic individuals were found to have consistently 
enlarged brain volumes throughout life.  Autism is a heterogenous disorder and it is 
possible that differences in the method used to identify autistic subjects between the 
current study and those in the meta-analysis may account for these differences.  The 
current studied used the SCQ, a screening instrument based upon the ADI-R, to delineat
the groups whereas the majority of studies included in the meta-analysis used much 
stricter diagnostic criteria for autism, usuallya combination of the ADI-R, ADOS
DSM criteria.  The latter approach is clearly more likely to pick out truly autistic subje
but it has the drawback that it those identified may represent a subgroup of the autistic 
population with more severe symptoms than the generality of this population.  It is 
possible that more severely affected autistic individuals show lifelong brain enlarg


















7.3  Comorbidity of Pervasive Developmental Disorders and Schizotypy 
 
Clinical Features 
When the main PDD-NOS group is divided into those with and without schizotypal 
features it becomes apparent that the high rates of psychopathology in this group are in 
fact driven by the group which is comorbid for PDD-NOS and schizotypy.  This 
comorbid PDD-NOS group have similar levels of psychotic phenomena to the SIS+ 
subjects and higher rates of other symptoms such as fatigue, irritability and depression  
They are markedly dissimilar to the non-comorbid PDD-NOS group who have low rate
of morbid pathology on most of the measured symptom.   
  
Neurostructural data  
s 
 similar pattern to the MRI findings is seen to the clinical findings described above.  
gain the comorbid PDD group appear to be broadly similar to the SIS+ group while 
ose with PDD-NOS alone differ significantly from both.  There are no significant 
ifferences between the autism and the comorbid autism groups with the right prefrontal 
I being similarly reduced in both, albeit the main effect was non-significant for this 
easure.  It is worth noting that the autism group did have non-significantly larger 
refrontal lobes than the comorbid autism group and it is possible that this lack of 
ignificance relates to issues of power.   
oth the clinical and the brain structural data are in keeping with the hypothesis that 














have features of PDD, bear more resemblance to schizotypal individuals than they do to 
ose with PDD alone.  In contrast the comorbid autism group are more similar to the 
to the SIS+ group which suggests that these individuals have 
th
autism group than 
schizotypal features as part of their autism as opposed to a primary diagnosis of 





















7.4  Limitations of the Study 
 
There are a number of important limitations to the current study which require 
consideration.  It is important to note that while the cut-offs on the SIS and the SC
empirically an
Q are 
d independently derived, neither of these instruments are intended as 
iagnostic tools.  Hence, each of the groups derived from these rating scales do not 
ecessarily conform to actual diagnostic categories and thus may contain individuals with 
arying clinical pictures.  However such heterogeneity is most likely to obscure 
ifferences between the groups meaning that from this perspective the results reported 
hould be regarded as conservative.  In addition, this risk of type II error is compounded 
 the final analysis by the small group sizes.   
he population examined is a heterogeneous one and some subjects will have specific 
ducational impairments over and above the schizotypal and autistic features that define 
e subject groups.  Should one of these impairments be more greatly represented in one 
f the subject groups compared to others then it is possible that any differences found 
ay be due to this and not to the feature which defines the groups.  However, given the 
eurodevelopmental nature of schizotypy and of pervasive developmental disorders it is 
kely that any such increase in specific impairments would be related to the cognitive 
eficits known to be associated with the disorders themselves.   
he issue of more general IQ impairments and their relationship with each of the groups 





















analyses as well as the normal control group.  Disagreements exist about whether the use 





up in addition to a healthy control group 
nd in fact most of the differences found in the current study were present when the 
is 
 
o have arisen by chance 
lone but caution is urged in the interpretation of results which were not predicted prior 
o
are many who argue that low IQ is part of the autistic syndrome and that to use 
matched control group will obscure differences which relate to the syndrome itself.240  
There are also difficulties in the selection of an appropriate IQ matched group – doe
choose a defined syndrome such as Down syndrome or a idiopathic low IQ group w
will be confounded by a number of factors such as obstetric complications and 
socioeconomic deprivation.  The contrary argument is that by not taking into acc
one risks false positive findings that are related to general cognitive impairment rather 
than to autistic features.146  There is no definitive answer to this problem, however it 
seems prudent to use an IQ matched control gro
a
subject groups were compared to either group of controls.   
 
Finally, no attempt was made to correct for multiple comparisons thus inflating the risk 
of a type I error particularly in the structure-symptom analysis which was post-hoc.  It 
worth noting that more significnant results were returned than one would expect through
chance alone (i.e. more than 1 in 20 tests were significant) but many of the differences 
would not remain significant if a correction for multiple comparisons was applied.  Those 
results which confirmed predetermined hypotheses are unlikely t
a
to undertaking the experiment, e.g. the reduction in GI seen in the autism group and the 
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structure-symptom relationships.  These results are still valuable in guiding future 

























7.5  Final Remarks and Directions for Future Research 
 
At present all psychiatric diagnoses are based on the subjective assessment of expressed 
oughts and observed behaviours and are thus imperfect categories with considerable 
verlap.  In individuals with cognitive impairment the discrimination between diagnostic 
ategories is further complicated by other factors such as low IQ and poor 
ommunication skills.  The work presented in this thesis represents the first steps in 
etermining the relationship between overlapping disorders in this population and in 
elineating the diagnostic boundaries between them.  In Chapter 1 two possible 
lationships between schizotypy and ASD were proposed, i.e. they may represent part of 
e same spectrum of disorders or they may represent discrete disorders with overlapping 
henotypic features.  The data presented above support the latter hypothesis, with 
ifferences between PDD, autism and schizotypy being apparent both clinically and at 
e neurostructural level.  In addition, it may be that within the broader population of 
dividuals with PDD there is a group with features consistent with a diagnosis of PDD 
ut who are in fact suffering from a schizophrenia spectrum disorder.   
he future development of objective diagnostic methods to discriminate psychiatric 
isorder has clear benefits for the management and prognosis of affected individuals and 
us for the provision of appropriate clinical services.  Using the conditions considered in 
is thesis as an example, it is possible that schizotypal individuals may gain benefit from 






















antipsychotics in PDD is becoming increasingly common and it may be that there are 
ly some who are not.  In 
ddition, the selection of appropriate psychological treatment is hampered by an unclear 
r 




sychiatric symptoms and may confirm the predictions of a reduction in prefrontal 
g genetic 
some people who are unnecessarily medicated and converse
a
diagnosis - clearly if an individual is socially withdrawn due to the presence of ideas of 
reference then they will require different treatment strategies to those who lack desire fo
social contact at all.  The prognostic issues are of equal if not greater importance due to 
the possibility that in schizophrenia early treatment of high risk individuals
delay or even avert the onset of illness.241   
 
The first step in developing the findings presented above is to carry out a more d
parcellation of the frontal lobe and to examine the temporal lobe, abnormalities of which 
are implicated by the reduced size of the isthmus in the schizotypal group.  This would 
elicit any differential enlargements or reductions in these lobes and provide further
information as to exactly which parts of the brain are responsible for the phenotypic 
features of autism and schizotypy.  As part of the ESC each of these individuals will 
receive a second MRI scan around 18-24 months after the first assessment.  As it was in 
the EHRS, this is likely to be highly informative with regard to the evol
p
volume around or before the onset of schizophrenia.   
 
In addition to the clinical and neuroimaging data there is a raft of other data collected on 
these individuals as part of the ESC.  This includes neuropsychological measures of 
frontal lobe function and memory, and putative aetiological variables includin
146 
 
data, early medical history and obstetric complications.  Examination of the 
neuropsychological measures with respect to brain structure may shed light on the nat
of the abnormalities observed on MRI, in particular whether they are deleterious or 
compensatory.  This will be especially useful if changes in neuropsychological function 
over time are compared to brain structural changes over the same period.  Although not 
part of the current data collection for the ESC, it is highly likely that functional MRI and
diffusion tensor imaging would also provide further insights into the nature of brain 
structural changes.  Finally the aetiological d
ure 
 
ata should be examined with respect to brain 






le.   
st
development of disorder and hence possible targets for future intervention.   
 
Moving beyond the ESC, further research is required to examine the nature of the overla
between autism and schizotypy.  The findings presented above suggest that diagnost
confusion could lead to the misclassification of schizotypal individuals as suffering fr
PDD.  However the groups were small and the SIS and SCQ ratings do not necessaril
reflect true diagnostic categories therefore future studies should use large, well defined 
groups.  Such studies may lead to the development of criteria that reliably separa
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